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ABSTRACT
ROLES OF TNFAIP8 IN
CELL MIGRATION AND PHOSPHOINOSITIDE SIGNALING
Mei Lin
Youhai H. Chen, M.D., Ph.D.
Well-coordinated directional cell migration is essential for diverse physiological
processes such as embryogenesis and immune responses, while its dysfunction can lead to
many pathological conditions including cancer and chronic inflammatory diseases. How
shallow gradients of chemoattractants translate into the axes of cellular polarization and
direct migration remain not well understood. In this study, we have employed loss- and
gain-of-function approaches and found that TNFAIP8-deficient human myeloid HL-60
cells exhibit reduced growth and migratory capacity. TNFAIP8 can serve as a cytosolic
inhibitor of Rac/Cdc42 and function through the PAK-LIMK-cofilin pathway, thus
controlling trailing edge formation. Biochemical studies and cell-based approaches
revealed that TNFAIP8 can interact with PtdIns(4,5)P2 and PtdIns(3,4,5)P3 through the
conserved TIPE homology (TH) domain. TNFAIP8 can steer cells by enhancing PI3Ks
activity and PtdIns(4,5)P2-dependent actin remodeling through cofilin, reinforcing a
positive feedback loop that amplifies phosphoinositide signaling at the leading edge.
Consequently, TNFAIP8 is required for chemoattractant-induced polarization by acting as
a “dual-role regulator” in cytoskeletal dynamics in response to external stimuli.
Additionally, using experimental autoimmune encephalomyelitis (EAE) as a mouse model
for multiple sclerosis (MS), we found TNFAIP8 and TIPE2 play redundant roles in
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controlling lymphocyte migration and infiltration. Our results support that TNFAIP8 is
important in inflammation and tumorigenesis, and represents a potential pharmaceutical
drug target to block cell migration for treating human diseases such as cancer.
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CHAPTER 1

INTRODUCTION AND BACKGROUND
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1.1 Cell migration
Cell migration plays an essential role in diverse physiological processes such as
embryogenesis, immunity and cancer metastasis (Lauffenburger & Horwitz, 1996; Ridley
et al., 2003). It is implicated in various fundamental activities including coordinated cell
layer movements during gastrulation and embryonic morphogenesis, renewal of adult skin
and intestine during tissue repair, and leukocyte infiltration during immune surveillance.
Dysregulation of eukaryotic cell migration contributes to many pathological conditions,
including chronic inflammatory diseases, cancer metastasis, as well as cardiovascular
diseases (Lauffenburger & Horwitz, 1996; Paul, Mistriotis, & Konstantopoulos, 2017;
Ridley et al., 2003).
Leukocytes are characterized by the ability to migrate rapidly up against shallow
gradients of chemoattractants (referred to as chemotaxis), which is important for immune
homeostasis and inflammation (Bloes, Kretschmer, & Peschel, 2015; Gregor, Foeng,
Comerford, & McColl, 2017; Jin, Xu, & Hereld, 2008; Kunkel & Butcher, 2002).
Leukocytes are normally quiescent as they travel within blood vessels. They migrate into
the infected tissue by responding to a variety of chemokines, cytokines or chemicals
released by bacteria. The central nervous system (CNS), for example, is an
immunologically “privileged” site to which access of leukocytes is tightly controlled by
the blood-brain and blood-cerebrospinal fluid barriers (Engelhardt & Ransohoff, 2012;
Minagar & Alexander, 2003). The infiltration of the CNS by circulating leukocytes is a
common pathogenic mechanism of multiple sclerosis (MS), one of the most common
autoimmune disorders (Calabresi et al., 2014; Derfuss, Kuhle, Lindberg, & Kappos, 2013).
2

It is estimated that around 1,000,000 individuals worldwide are afflicted by multiple
sclerosis. Drugs blocking leukocyte chemotaxis such as the FDA-approved fingolimod and
natalizumab are highly effective for treating chronic inflammatory diseases like multiple
sclerosis (Calabresi et al., 2014; Derfuss et al., 2013).
Cancer cell locomotion is another important form of eukaryotic cell migration.
Failure to treat cancer metastases from solid tumors in clinic has been responsible for the
majority of patient deaths (Gupta & Massagué, 2006; Steeg, 2016). The importance of
tumor cell metastasis has been demonstrated through physiologically relevant confined
tracks in vivo by time-lapse, deep-tissue imaging of intravital microscopy. (Alexander,
Koehl, Hirschberg, Geissler, & Friedl, 2008; Alexander, Weigelin, Winkler, & Friedl,
2013) The cascades for metastasis are complicated and encompass migration of cancerous
cells away from the primary site, intravasation into the circulation system, extravasation to
secondary tissues and formation of distant metastatic tumors (W. Wang et al., 2005). Cell
migration is a pivotal step during these metastatic processes (Talmadge & Fidler, 2010;
Wirtz, Konstantopoulos, & Searson, 2011). Polarization is crucial for directional
migration, with the formation of a filamentous actin-rich lamellipodium at the front and
uropod at the rear (Sánchez-Madrid & Angel del Pozo, 1999). A better understanding of
cancer cell motility and relevant mechanisms could be useful in developing therapeutic
strategies to abate metastasis-initiating migration in the clinic to combat metastasis.
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1.2 Phosphoinositide signaling
Phosphatidylinositol (PtdIns) is a unique membrane phospholipid that can be
phosphorylated at the 3, 4 and 5 positions of the inositol ring to generate seven
phosphoinositides:

PtdIns3P,

PtdIns4P,

PtdIns5P,

PtdIns(3,4)P2,

PtdIns(3,5)P2,

PtdIns(4,5)P2 (PIP2) and PtdIns(3,4,5)P3 (PIP3). Among these, PtdIns(4,5)P2 and
PtdIns(3,4,5)P3 are important lipid second messengers (Swaney, Huang, & Devreotes,
2010; Vivanco & Sawyers, 2002). PtdIns(4,5)P2 is the most abundant phosphoinositide
and binds to proteins important for actin polymerization, focal contacts formation and cell
adhesion (Thapa & Anderson, 2012). PtdIns(4,5)P2 has been proposed to control cell
migration through at least three mechanisms: (i) it can maintain cell shape by linking the
actin cortex to the membrane via interactions with class I myosins as well as
Ezrin/Radixin/Moesin (ERM) proteins; (ii) it can act as a second messenger exerting direct
signaling roles through interacting with its effector proteins mediated by defined
modules/domains; (iii) it is the precursor of at least three important second messengers:
PtdIns(3,4,5)P3 generated through phosphorylation by Phosphoinositide 3-kinases
(PI3Ks), as well as inositol 1,4,5-trisphosphate [I(1,4,5)P3 or IP3] and diacylglycerol
(DAG) generated through hydrolysis by phospholipase C (PLC).
Localized accumulation of phosphatidylinositol lipids has been proposed to be the
key event directing the recruitment and activation of signaling components required for
chemotaxis. PtdIns(3,4,5)P3 is highly enriched in the leading edge and controls cell
migration by promoting actin polymerization through both GTPase-dependent and
independent mechanisms (Thapa & Anderson, 2012). Upon the chemoattractant
4

stimulation, PI3K is locally activated by ligand-bound G-protein coupled receptors
(GPCRs) or receptor tyrosine kinases (RTKs). Active PI3K catalyzes phosphorylation at
the 3 position of PtdIns(4,5)P2 to generate PtdIns(3,4,5)P3, which leads to its enrichment
at the leading edge. Also in cancer cells, PI3K generation of PtdIns(3,4,5)P3 and the
subsequent activation of Akt and its downstream cascades (e.g., mTORC1) compose the
signaling axis controlling cell survival, proliferation and growth (Merlot & Firtel, 2003;
Swaney et al., 2010). The asymmetric distribution of PtdIns(3,4,5)P3 is also confined
spatially by the actions of 3’ lipid phosphatases, which convert PtdIns(3,4,5)P3 back to
PtdIns(4,5)P2. Phosphatase and tensin homolog on chromosome ten (PTEN) is enriched at
the back and sides of migratory cells. The Src homology phosphatases (SHIP1 and SHIP2)
are also active within cells and can locally dephosphorylate PtdIns(3,4,5)P3 at the 5’
position to produce PtdIns (3,4)P2, thereby adjusting the local phosphoinositides
composition (Thapa et al., 2016; Tsujita & Itoh, 2015).

1.3 Rho family of small GTPases
Rho family of small GTPases are central signaling molecules of cell migration. It
belongs to the Ras GTPases superfamily and is conformationally regulated by the binding
of GTP and GDP. When bound to GTP, it is active and interacts with downstream effector
proteins. These GTPases are activated by guanine nucleotide exchange factors (GEFs) and
inactivated by GTPase activating proteins (GAPs). In addition, Rho family can bind to
guanine nucleotide dissociation inhibitors (GDIs), which prevent its interaction with the
5

plasma membrane but not necessarily downstream targets (Hansen & Nelson, 2001;
Ridley, 2001). Rho GDP-dissociation inhibitors (RhoGDIs) consist of RhoGDIα,
RhoGDIβ and RhoGDIγ. Besides cell migration, Rho proteins have also been found to
mediate numerous other relevant processes such as cell adhesion to substrates and cells,
vesicle trafficking, protein secretion and transcription (Nobes & Hall, 1999; Schmidt &
Hall, 2002). Of the at least 20 Rho family proteins identified so far in human, Rac1/2,
Cdc42 and RhoA/B have been the most widely studied for their importance in cell
migration. Rac and Cdc42 are mainly active at the leading edge, contributing to spatially
confined actin polymerization and protrusion via Arp2/3 and WASP/WAVE dependent
mechanisms, while Rho is involved in rear retraction (Nobes & Hall, 1999; Sánchez‐
Madrid & Angel del Pozo, 1999).
The directed migration of cells requires membrane protrusion, attachment to the
substratum, and release of the cell rear followed by retraction of the tail (Sánchez-Madrid
& Angel del Pozo, 1999). Phosphoinositides including PtdIns(4,5)P2 and PtdIns(3,4,5)P3
are major second messengers relaying these signals from receptors and exert their functions
through interacting with PIP effectors such as pleckstrin homology (PH) domain and
polybasic motif (PBM) proteins (Rickert, Weiner, Wang, Bourne, & Servant, 2000; Tsujita
& Itoh, 2015; Li Zhang, Mao, Janmey, & Yin, 2012). A subset of PH-proteins includes
GEFs and GAPs for the Rho family. During chemotaxis cells are polarized, with a
filamentous actin-rich lamellipodium at the front and uropod at the rear (Sánchez-Madrid
& Angel del Pozo, 1999). This front-to-rear polarity is essential for directional migration,
and many polarity complexes, including the Par complex, Crumbs complex and Scribble
6

complex, are conserved across species and diverse cell types (Crespo et al., 2014;
Kamakura et al., 2013). There have been reports on crosstalk between Rho proteins and
members of polarity complexes in regulating polarity formation. For example, the Rac
activator T-cell-lymphoma invasion and metastasis-1 (TIAM1) binds to partitioning
defective-3 (PAR3) polarity protein, connecting Rac activities to polarity signaling
(Mertens, Rygiel, Olivo, van der Kammen, & Collard, 2005; Nishimura et al., 2005).

1.4 TIPE protein family
The TIPE (tumor necrosis factor-a-induced protein 8 (TNFAIP8)-like, or
TNFAIP8L) family of proteins are newly discovered regulators of inflammation and
tumorigenesis. There are four highly homologous mammalian TIPE family members:
TNFAIP8, TIPE1 (TNFAIP8L1), TIPE2 (TNFAIP8L2) and TIPE3 (TNFAIP8L3). TIPE
proteins have been reported to be risk factors for inflammation and cancer, and their
expressions are dysregulated in a number of human diseases (Ahn et al., 2010; Goldsmith,
Fayngerts, & Chen, 2017; Hao et al., 2016; Y. Zhang et al., 2012).
TNFAIP8, also known as SCC-S2, is the founding member of TIPE family.
TNFAIP8 is expressed in numerous human normal tissues and found to be frequently overexpressed in a wide range of human cancers and promote tumor metastasis (L. Chen et al.,
2016; Dong et al., 2010; Duan, Zhu, Guan, & Wang, 2014; Kumar et al., 2004; Li et al.,
2015; Z. Sun et al., 2016; Yang et al., 2014; C. Zhang et al., 2013; Y. Zhang et al., 2012).
TNFAIP8 is also a risk factor for multiple sclerosis (Hussman et al., 2016) and plantar
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fasciitis (S. K. Kim et al., 2018) as revealed from recent genome-wide association studies
(GWAS). TNFAIP8 is expressed in various human cancer cell lines, with relatively higher
mRNA levels in K562 chronic myelogenous leukemia cells, MOLT4 lymphoblastic
leukemia cells and A549 lung carcinoma cells (Kumar et al., 2000).
TIPE2 was initially identified as one of the most highly upregulated genes in the
spinal cord of experimental autoimmune encephalomyelitis (EAE) mice, and later found
to preferentially express in murine leukocytes (H. Sun et al., 2008). Of the four members
of the human TIPE family, TIPE2 is almost exclusively expressed in hematopoietic cells.
TIPE2 is reported to be a negative regulator of innate and adaptive immunity and essential
for maintaining immune homeostasis (Gus-Brautbar et al., 2012; Lou et al., 2014; H. Sun
et al., 2012; Z. Wang et al., 2012). TIPE2 can regulate both carcinogenesis and
inflammation (Gus-Brautbar et al., 2012), and is crucial for the polarization of myeloid
cells (Fayngerts et al., 2017; H. Sun et al., 2008). TIPE2-deficient leukocytes are hyperresponsive to Toll-like receptors (TLRs) activation and exhibit enhanced phagocytic and
bactericidal activities, and TIPE2-deficient mice are more sensitive to intravenously
induced septic shock (H. Sun et al., 2008; Z. Wang et al., 2012).
TIPE1 is a less well characterized member of TIPE family. TIPE1 has been found
to be expressed in various murine tissues and human cancer cell lines (Cui et al., 2011).
Knockdown of TIPE1 inhibited TNFa and zVAD.fmk-induced necroptosis in L929 and
NIH3T3 cells (Hitomi et al., 2008), and can induce apoptosis by negatively regulating Rac1
activation in hepatocellular carcinoma cells (Z. Zhang et al., 2015), suggesting TIPE1 may
be a potential component of the necroptosis and apoptosis pathways. Additionally, studies
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have shown that TIPE1 can function as a prognosis predictor and negative regulator of lung
cancer (Wu et al., 2017), and suppress invasion and migration through downregulating
Wnt/β-catenin pathway in gastric cancer (Liu et al., 2018).
TIPE3 is reported to exhibit similar expression profiles in mice and human, and is
preferentially expressed in secretory epithelial tissues (Cui et al., 2015). TIPE3 expression
is also markedly upregulated in cervical, colon, lung and esophageal cancers (Cui et al.,
2015; Fayngerts et al., 2014). The recently resolved high-resolution crystal structure of
human TIPE3 reveals a large hydrophobic central cavity, which consists of 7 alpha helixes
forming a pocket that measures 20 Angstrom in depth and 10 Angstrom in diameter.
Although the outer surface is highly charged, the central cavity is predominantly
hydrophobic, which is indicated to confer lipid binding capacity (Fayngerts et al., 2014).
Additionally, TIPE3 can act as a transfer protein for lipid second messengers that include
PtdIns(4,5)P2 and PtdIns(3,4,5)P3, and potentiate PI3K signaling (Fayngerts et al., 2014).

1.5 TNFAIP8 and cancer
TNFAIP8 has been implicated in inflammation and tumorigenesis. It is originally
identified as one of the most differentially expressed genes in primary and matched
metastatic head and neck squamous cell carcinoma (HNSCC) from the same patient
(Kumar, Whiteside, & Kasid, 2000; Patel, Wang, Whiteside, & Kasid, 1997). High
expression of both TNFAIP8 mRNA and protein has been detected in various clinical
specimens compared to healthy tissues. Studies have reported TNFAIP8 as a risk factor for
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the progression and poor prognosis of numerous human malignancies, including prostate
cancer (C. Zhang et al., 2013), gastric adenocarcinoma (L. Chen et al., 2016; Hu et al.,
2016; Li et al., 2015; Yang et al., 2014), esophageal squamous cell carcinoma (ESCC) (Z.
Sun et al., 2016), non-small-cell lung cancer (Dong et al., 2010) and non-Hodgkin’s
lymphoma (Y. Zhang et al., 2012). We have confirmed high TNFAIP8 protein levels in
multiple human and mouse cancer cell lines through immunoblot analysis and HL-60 is
among the most highly expressing cell lines (Figure 1.1A, B).
Experimental evidence supports the notion that TNFAIP8 plays an important role
in oncogenesis. For example, exogenous expression of TNFAIP8 in MDA-MB 435 human
breast cancer cells enhances proliferation and invasion in vitro, as well as experimental
metastasis in vivo (C. Zhang et al., 2006), while knocking TNFAIP8 down reduces the
tumorigenicity in SGC-7901 and MKN-28 gastric cancer cell lines (Li et al., 2015). The
precise functions of TNFAIP8 in carcinogenesis and its mechanisms of actions remain
largely unknown.
Human TNFAIP8 has six transcript variants (Variant 1 to Variant 6) with different
transcription start sites and exons, and can be translated to four protein isoforms (Isoform
a to Isoform d). All transcript variants share the last exon: Variants 1 and 3 share another
exon, while Variant 3 has a unique first exon; Variants 2, 5, and 6 share a first exon, and
Variants 5 and 6 share a unique second exon (Figure 1.2). Among these recently described
expression transcript variants, Variants 3 to 6 are minimally expressed in normal or cancer
tissue through the analysis of RNA-seq database (Lowe et al., 2016), whereas Variant 2 is
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frequently overexpressed in multiple human malignancies, and Variant 1 is commonly
downregulated in cancer.
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Figure 1.1 TNFAIP8 protein is highly expressed in various cancer cell lines
(A, B) Immunoblot analysis of TNFAIP8 protein levels in various human (A) and mouse
(B) cancer cell lines. GAPDH serves as a loading control, and purified human TNFAIP8
isoform b protein is used for quantification. d, differentiated.
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A
Transcript (length)

Protein (length)

Variant 1 (2,103 bp)
Variant 2 (2,107 bp)

Isoform a (198aa)
Isoform b (188aa)

Variant 3 (2,520 bp)
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Variant 5 (2,135 bp)
Variant 6 (2,139 bp)

Isoform d (166aa)
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Figure 1.2 The six TNFAIP8 transcript variants (Variant 1 to Variant 6) and four
protein isoforms (Isoform a to Isoform d) in humans
(A) At left, the genomic structure is shown for the six transcript variants according to
Ensembl genome database. Each rectangle represents an exon. All variants share the last
exon (indicated by light blue rectangle). Variant 6 has four additional nucleotides
“ACAG” which are immediately upstream of its second exon compared to Variant 5. At
right, the length in base pairs (bp) and amino acids (aa) are shown for each transcript.
Adapted from (Lowe et al., 2016).

13

1.6 Hypothesis and specific aims
The ability of cells to migrate up against shallow gradients of chemoattractants
requires the temporal and spatial regulation of molecular machineries to sense chemokine
gradients by receptors, induce polarized morphology, and rapidly reorganize the
cytoskeleton (Jin et al., 2008; Sánchez‐Madrid & Angel del Pozo, 1999). Despite intensive
studies, how the shallow gradients of chemoattractants translate into axes of cell
polarization during chemotaxis remains not well understood. In order for cells to move in
one direction, they must first form a defined front (leading edge) and rear (trailing edge).
This front-rear polarity is characterized by asymmetrical activation of proteins such as
PI3Ks, Rho GTPases and actin regulatory proteins at the leading and trailing edges. While
somatic mutations of PI3Ks, PTEN and Ras account for many cases of the aberrant
phosphoinositide signaling, other mechanisms for its dysregulation are also being
discovered (Thapa et al., 2016; Vivanco & Sawyers, 2002).
The precise cell type-specific functions of TIPEs remain unknown. The highresolution crystal structures of murine Tnfaip8 C165S mutant, human TIPE2 and human
TIPE3 have recently been resolved (Fayngerts et al., 2014; J.-S. Kim et al., 2017; D. Lee
et al., 2014; X. Zhang et al., 2008). They reveal a conserved TIPE homology (TH) domain
composed of a large hydrophobic central cavity, which implicates lipid binding capacity.
In our lab, it has been previously demonstrated that TIPE2 and TIPE3 can function through
lipid second messengers that include PtdIns(4,5)P2 and PtdIns(3,4,5)P3 (Fayngerts et al.,
2017, 2014). In addition, TIPE2 can direct leukocyte polarization (Fayngerts et al., 2017)
and directly bind and inhibit Rac (Z. Wang et al., 2012). However, it’s not clear if each
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TIPE family member shares the same mechanisms of actions in cell migration and
tumorigenesis.
Our Specific Aim 1 is to test the hypothesis that TNFAIP8 can promote
tumorigenesis through Rho GTPase-dependent signaling pathways. We will use both lossand gain-of-function approaches to manipulate TNFAIP8 expression in HL-60 cell line,
and characterize the phenotypical and functional outcomes. We expect that TNFAIP8
knockout cells would have reduced growth and migratory capacity, and aberrant molecular
pathways downstream of Rac/Cdc42 activation. Specific Aim 2 is to test the hypothesis
that TNFAIP8 can steer cells by enhancing phosphoinositide signaling and remodeling
PtdIns(4,5)P2-dependent actin dynamics. Both biochemical and cell-based approaches will
be used to investigate the functional significances of the hydrophobic central cavity and
electrostatic interactions of α0 helix from TIPE homology (TH) domain. We expect that
TNFAIP8 mutants deficient in phosphoinositide interactions will be incompetent to rescue
the cellular defects of TNFAIP8 knockout HL-60s. Specific Aim 3 is to test the hypothesis
that TNFAIP8 and TIPE2 have redundant roles in controlling murine lymphocyte
migration, using experimental autoimmune encephalomyelitis (EAE) as a mouse model for
neural inflammation. This study will advance a better understanding of TIPE family in
inflammation and tumorigenesis, and advise effective pharmaceutical drug design to
enhance or block their activities for treating human diseases such as cancer.
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CHAPTER 2

TNFAIP8 PROMOTES CANCER
CELL MIGRATION
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2.1 Introduction
Most of our knowledge about TIPE family proteins has come from animal studies,
therefore there is a knowledge gap and necessity to characterize human TIPEs in both
health and diseases. To investigate whether the roles of TIPE family are conserved in
human, and to facilitate further mechanistic studies, we used CRISPR/cas9 to knock out
TNFAIP8 in HL-60, a human promyelocytic leukemia cell line that can be conveniently
differentiated into neutrophil-like cells in vitro (Collins, 1987; Gallagher et al., 1979;
Klinker, Wenzel-Seifert, & Seifert, 1996). We have confirmed that dHL-60 cells express
highest level of TNFAIP8 protein among all the cell lines examined (Figure 1.1A, B).
Cell adhesion plays an essential role in leukocyte extravasation to inflamed tissue,
and the ability of neutrophils to regulate adhesion derives from their ability to control the
affinity states of integrins. Integrin “inside-out” signaling is the process where signals
inside the cells cause the external domains of integrins to assume an activated state
(Ginsberg, Du, & Plow, 1992; Harburger & Calderwood, 2009; Takagi, Petre, Walz, &
Springer, 2002). Lymphocyte function-associated antigen 1 (LFA-1) is an integrin found
on neutrophils and other leukocytes. Its affinity is activated by several signaling events
including G protein coupled receptor (GPCR) activation, chemokine and cytokine
stimulation, and T cell receptors (TCR)-mediated signals, which allows cells to undergo
arrest resulting in firm adhesion on endothelia expressing intercellular adhesion molecules
(ICAMs) (Springer & Dustin, 2012). In this study, we will use fMLP and TNFα stimulation
for HL-60 static adhesion assay on fibronectin or ICAM-1 coated surfaces.
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During migration, active Rac-GTP preferentially localizes at the front of the cell,
while at the trailing uropod Rac is inactive, which prevents the formation of multiple
lamellipodia (Ridley, 2001). Rac-GTP promotes actin polymerization through their
effector proteins such as p21-activated kinases (PAKs) and WASP-family verprolinhomologous protein (WAVE) (Nobes & Hall, 1999). Cdc42 can bind and activate the Par
polarity complex, which could in turn activate Rac through Tiam1 (Etienne-Manneville,
2004). TIPE2 has been previously reported to be able to inhibit Rac membrane
translocation/activation and suppress Rac downstream signaling (Z. Wang et al., 2012).
When expressed using an in vitro transcription-translation system and mixed together,
TIPE2 and Rac can physically associate and directly bind to each other. The hydrophobic
C-terminal CAAX motif region of Rac has been found to be responsible for this interaction
and targeting/anchoring Rac to the plasma membrane (Z. Wang et al., 2012). The
interactions between TNFAIP8 and other Rho family of small GTPases remain to be
explored.
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2.2 Materials and Methods
2.2.1 Cell lines and culture
The cell lines were obtained from the American Type Culture Collection (ATCC)
or Clontech. HEK293T cell line, LentiX-293T cell line, PANC-1 pancreatic carcinoma cell
line, EL-4 T cell lymphoma cell line, WEHI 7.1 T cell lymphoma cell line, Hepa 1-6
hepatoma cell line, B16-F0 melanoma cell line, B16-F10 melanoma cell line, Fibrosarcoma
573 cell line and Raw 264.7 macrophage cell line were cultured in Dulbecco's Modified
Eagle Medium (DMEM) with 10% FBS, 1% L-glutamine and 1% Penicillin-Streptomycin
(D10 medium). U-937 lymphoma cell line, NCI-H69 small cell lung cancer cell line, NCIH727 lung cancer cell line, AsPC-1 pancreatic adenocarcinoma cell line and MT-901
mammary carcinoma cell line were cultured in RPMI-1640 with 10% FBS, 1% Lglutamine and 1% Penicillin-Streptomycin (R10 medium). T24 urinary bladder cancer cell
line and HT-29 colorectal adenocarcinoma cell line were cultured in McCoy's 5A medium
containing 10% FBS and 1% Penicillin-Streptomycin. HEC-1-B uterus adenocarcinoma
cell line and Neuro-2a neuroblastoma cell line were cultured in Eagle's Minimum Essential
Medium (EMEM) composed of Minimum Essential Medium (MEM) containing 1× NonEssential Amino Acids (NEAA), 1% L-glutamine, 1 mM sodium pyruvate, 10% FBS and
1% Penicillin-Streptomycin. SW480 colorectal adenocarcinoma cell line was cultured in
Leibovitz's L-15 medium containing 10% FBS and 1% Penicillin-Streptomycin. HL-60
promyelocytic leukemia cell line was cultured in R10 medium supplied with 25 mM
HEPES. As HL-60 cells would acidify their medium quite rapidly, 25 mM HEPES is
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essential to counterbalance the pH in culture. HL-60 cell concentration was kept between
1.5 x 105 to 10 x 105 cells/ml during passage. In order to supply cells of the same quality,
frozen cells of the same lot were thawed every two months and used for experiments. HL60 cells were differentiated by 1.25% (vol/vol) DMSO and 5 ng/ml human G-CSF
continuously in culture for 4-6 days before harvest for experiment (cell density was kept at
1.5-2.5 x 105 cells/ml). Cell cultures were examined periodically for bacteria contamination
and tested for Mycoplasma by LookOut Mycoplasma PCR Detection Kit (Sigma).

2.2.2 Generation of TNFAIP8-deficient HL-60 single clonal cell line by
CRISPR/Cas9 system
TNFAIP8-deficient HL-60 cells were generated using CRISPR/Cas9 system and
TNFAIP8-specific single guide RNA (sgRNA) or non-targeting control single guide RNA
(sgControl) as described (Cho, Kim, Kim, & Kim, 2013; Cong et al., 2013; Garneau et al.,
2010; Hsu et al., 2013; Jinek et al., 2012; H. Kim & Kim, 2014; Mali et al., 2013; Ran et
al., 2013; T. Wang, Wei, Sabatini, & Lander, 2014). Three sgRNAs were designed to target
the earliest sequences of the shared exon of human TNFAIP8 isoforms (Figure 1.2), with
optimal on-target and off-target scores (Table 1). The CRISPR target sequences were
cloned into LentiCRISPRv2 vector (Ran et al., 2013; Sanjana, Shalem, & Zhang, 2014;
Shalem et al., 2014) backbone by adding BsmBI digestion sites using specific primers
(Table 2).
Lenti-X 293T cells (Clontech) were pre-cultured in lentivirus packaging medium
containing Opti-MEM I reduced serum medium, 1× GlutaMAX, 1 mM sodium pyruvate
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and 5% FBS. The constructs were transfected into Lenti-X 293T cells along with 3rd
generation lentiviral packaging plasmids. Two batches of lentivirus were harvested,
concentrated by Lenti-X Concentrator (Clontech) and titrated by RT-qPCR titration kit
(Clontech) as well as antibiotic selection. The functional lentivirus titer was around 1.2
x106 Colony Forming Unit (CFU)/ml, and the HL-60 cells were infected at a multiplicity
of infection (MOI) of 10. The transduction efficiency measured by EGFP positive control
48 h post transduction was over 80%. The medium was replaced with selection medium
(complete culture medium with puromycin at 1 μg/mL final concentration) 48 h posttransduction, and was replaced with fresh medium containing puromycin every 2-3 days
until antibiotic-resistant colonies can be identified (around 4-7 days; a typical selection
with puromycin takes 7-10 days), while the cells in the untransduced well were dying. The
T7EI genomic cleavage detection (GCD) assay (IDT) was performed on the genomic DNA
of cells harvested before or three days post puromycin selection. Specific primers
amplifying the targeted sequences (Table 3) were used to confirm the efficiency of indel
formation following the editing experiments.
The puromycin-resistant cells were passed through a 40 μm cell strainer to break
up clumps and generate single cell suspension. The cell suspension was plated at suitable
density to TCS semi-solid methylcellulose-based medium (ClonaCell) according to the
manufacturer’s instructions. After 10-14 days the cultures were inspected for the presence
of colonies, and the single clones were picked and expanded in liquid medium for
cryopreservation and further analysis.
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Table 1
CRISPR sequences targeting the shared exon of all human TNFAIP8 isoforms

TNFAIP8 CRISPR sequence 1 5’- GGATAACACATTCCGGTCAA -3’
TNFAIP8 CRISPR sequence 2 5’- TCATCAGCTTGCTATGACCG -3’
TNFAIP8 CRISPR sequence 3 5’- AGGTGGATTATACCTTTGAC -3’

PAM Direction
AGG
(-)
TGG
(+)
CGG
(+)

Table 2
Primers for cloning the target sequences into the LentiCRISPRv2 backbone
Forward Oligo
Reverse Oligo
LentiCRISPRv2 TNFAIP8 sgRNA1 CACCGGATAACACATTCCGGTCAA AAACTTGACCGGAATGTGTTATCC
LentiCRISPRv2 TNFAIP8 sgRNA2 CACCGTCATCAGCTTGCTATGACCG AAACCGGTCATAGCAAGCTGATGAC
LentiCRISPRv2 TNFAIP8 sgRNA3 CACCGAGGTGGATTATACCTTTGAC AAACGTCAAAGGTATAATCCACCTC

Table 3
Primers of genomic cleavage detection (GCD) assay for CRISPR validation
sgRNA1 GCD Primer set1
sgRNA1 GCD Primer set2
sgRNA2 GCD Primer set1
sgRNA2 GCD Primer set2
sgRNA3 GCD Primer set1
sgRNA3 GCD Primer set2

Forward Oligo
TTTAGTTCGCTTCACTTG
TTAATTCTTTTCCTCTCTTTTT
CAAATGGTGGGAAAATGAGG
TTAGTTCGCTTCACTTGCTG
ATACCTGTTTTTAGTTCGCTTC
TTAATTCTTTTCCTCTCTTTTT
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Reverse Oligo
ACCATCACATAGTTTTTG
GGTTTAAAATTCCCAAAA
GGATTATACAAGGCAGCCAA
GGATTATACAAGGCAGCCAA
TAGTTTTTGTAAGTGGGG
GGTTTAAAATTCCCAAAA

GCD band size (bp)
600 [406 bp,194 bp]
540 [371 bp,169 bp]
603 [416 bp,187 bp]
556 [369 bp,187 bp]
600 [414 bp,186 bp]
540 [371 bp,169 bp]

2.2.3 Transwell migration/invasion assay of dHL-60 and inhibitors study
The migration of differentiated HL-60 towards chemoattractants was performed
using the 3 μm pore Transwell filters (Corning) as described (JoVE, Cambridge, 2016;
Justus, Leffler, Ruiz-Echevarria, & Yang, 2014). dHL-60 cells were centrifuged gently at
400g for 5 min, washed two times with DPBS, and rested in migration assay buffer for 30
min at 37°C. Migration assay buffer contains Hanks’ Balanced Salt solution (HBSS) with
Ca2+/Mg2+, 25 mM HEPES and 0.2% Human Serum Albumin (HSA, Sigma, fatty acid and
endotoxin free, freshly made). For the invasion assay, the filters were coated with 100 ul
of 50 μg/mL Matrigel (Corning), and the plate was placed at room temperature for 1 h to
solidify and form a thin gel layer. Just prior to cell seeding, the remaining Matrigel was
carefully aspirated from the inserts, washed once with DPBS, and 2 x 105 dHL-60 cells
were added using reverse pipetting method to avoid bubbles. When studying the effects of
inhibitors on transmigration, cell seeding volume was reduced to half (125 μl per well) to
allow for the addition of equal volume of test reagents in 2× concentration, and the cells
were pre-incubated with the antagonists for 45 min at 37°C before the start of the
experiment. The pharmacological inhibitors were used at the following final
concentrations: LY-294,002 (100 μM, Sigma), NSC 23766 (300 μM, Sigma), Torin1 (250
nM, Calbiochem), InSolution Z62954982 (100 μM, Calbiochem), Y-27632 (10 μM, Cell
Signaling Technology) and FRAX486 (10 μM, Sigma). fMLP and CXCL8 were added to
the bottom wells at the concentrations of 10 nM and 3 nM, respectively. dHL-60 cells were
allowed to migrate for 1.5 h at 37°C. Prewarmed cell detachment solution (0.05% TrypsinEDTA, no phenol red) was added to the lower chamber to dissolve any cells attached to
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the bottom of the insert. The numbers of cells migrated into the lower chamber and
detached by Trypsin-EDTA were quantified by CellTiter-Glo (CTG) assay (Promega). %
Migration = the number of cells that migrated in response to chemoattractant / the total
number of cells seeded on the chamber. The experiments were performed in duplicates or
triplicates.

2.2.4 Static adhesion assay
The 96-well TC-treated cell culture plates were coated with 40 μl of 50 μg/mL
fibronectin or 40 μl of 5 μg/mL ICAM-1 (diluted in DPBS) for 2 h at 37°C. Differentiated
wild-type and TNFAIP8 knockout dHL-60 cells were serum starved for 2 h in assay buffer
containing HBSS with Ca2+/Mg2+, 25 mM HEPES and 0.2% HSA. The cells were
subsequently stimulated with fMLP (100-200 nM) or TNFα (30 ng/mL) and plated on
fibronectin or ICAM-1 coated surfaces (washed cells were resuspended at the
concentration of 3.0 x 106 cells/mL; 50 μl was added in order to seed 1.5 x 105 cells per
well). The plates were incubated for 30 min at 37°C in a CO2 incubator. The plates were
then gently washed three times with HBSS buffer (with Ca2+/Mg2+) to remove cells that
were not able to form tight contacts with the ligands. Check under microscope to see if
many cells remain in HSA coated wells (cells in HSA negative control wells should be
rare; if not, repeat wash). The cells left in the wells were quantified by CellTiter-Glo (CTG)
assay (Promega). The average percentage of adherent cells is calculated relative to
unwashed wells that represent 100%.
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2.2.5 Lipid extraction from cells
Total lipids were isolated from cells as described (BLIGH & DYER, 1959; Clark
et al., 2011; Corey et al., 1993; FOLCH, LEES, & SLOANE STANLEY, 1957). Briefly,
the cells were pelleted by centrifugation at 400g for 5 min at 4°C, and washed one time
with ice-cold PBS. The cells were then resuspended in HBSS buffer with Ca2+ and Mg2+
at 3 x 107 cells/ml. Save 20 μl (around 0.6 x 106 cells) to lyse for harvesting actin protein
as loading control. Divide the left cells equally (340 μl, around 10.2 x 106 cells) into two
groups (unstimulated v.s. stimulated) in 15 ml conical tubes. Stimulate 340 μl (around 10.2
x 106 cells) aliquot of cells with 10 nM fMLP or vehicle for 60 sec at 37°C. Terminate
reactions by addition of 1500 μl quench mix (75 ml stock comprised of 48.4 ml methanol,
24.2 ml chloroform and 2.355 ml 1 M HCl; stock solution prepared using standard
glassware). The above steps created primary lipid extracts from cells, which resulted in a
thoroughly mixed, single-phase sample (from 340 μl of aqueous sample and 1500 μl of
quench mix) in a 15 ml conical tube. 1450 μl CHCl3 was then added, followed by 30 sec
vortex and adding 340 μl 2 M HCl. The sample was then thoroughly mixed again and
centrifuged in a bench-top microcentrifuge at 1,500g for 5 min at room temperature. This
created a two-phase system with an upper aqueous layer and a lower organic phase, with a
protein band at the interface. The upper phase was siphoned, and the lower organic phase
(~1700 μl) was collected into a fresh 2 ml safe-lock polypropylene tube. The extracted
lipids were dried down with light nitrogen stream, and then speed-vacuumed at 35°C for 1
h. The dried lipids can be stored at -20°C or -80°C before experiments.
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2.2.6 Protein-lipid overlay assay
Cellular levels of PtdIns(3,4,5)P3, PtdIns(4,5)P2 and PtdIns(4)P were measured
using protein-lipid overlay assay with GST-GRP1-PH, GST-PLCδ-PH and GST-SidC-3C
domains, respectively (Dowler, Kular, & Alessi, 2002; Guillou et al., 2007; Rusten &
Stenmark, 2006). The extracted dried lipids were dissolved in a 1:1 mixture of chloroform
and methanol containing 0.1% HCl. 1-2 μl aliquots of the lipids were spotted onto
nitrocellulose membrane in a consistent pattern. The membranes were allowed to dry in
dark at room temperature for 1 h or at 4°C overnight. The membranes were then blocked
with TBS-T (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.05% (v/v) Tween 20 detergent)
containing 3% fatty acid-free BSA (Sigma), and gently agitated for 1 h at room temperature.
The membranes were then incubated with GST-PLCδ-PH, GST-GRP1-PH or GST-SidC3C (0.5-1.0 μg/ml, Echelon) in TBS-T with 3% fatty acid-free BSA for 1 h at room
temperature. Proteins were detected with anti-GST-HRP antibody (Cell Signaling
Technology) and chemiluminescence (Pierce). For dot blot studies control membranes
were stained with anti-GST-HRP only. For normalization, a small aliquot of cells was lysed
in RIPA lysis buffer with protease and phosphatase inhibitors. The lysates were spotted on
membranes and immunoblotted with anti-actin (Sigma, 1:4000 dilution) and HRPconjugated secondary anti-mouse IgG (1:3000 dilution).
For protein-lipid overlay assay of 6His-SUMO tagged TNFAIP8 mutants, the
synthetic lyophilized lipids were reconstituted to 1 mM stocks in a 1:1 solution of methanol
and chloroform and stored at -80°C before use. DOPC (Avanti Polar Lipids), DOPS
(Avanti Polar Lipids), PtdIns(4)P (CellSignals), PtdIns(4,5)P2 (CellSignals) and
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PtdIns(3,4,5)P3 (CellSignals) were spotted onto nitrocellulose membranes and processed
as described above. The membranes were then incubated with 10 nM purified TNFAIP8
or mutant proteins in TBS-T with 3% fatty acid-free BSA, and the binding was detected
with anti-6His-HRP antibody (Cell Signaling Technology). Signals were then revealed by
chemiluminescence (Pierce) and quantified by desitometry using ImageStudioLite (LICOR Biosciences) software.
For the estimation of PtdIns(3,4,5)P3 levels in splenocytes and CD4+ T cells,
PtdIns(3,4,5)P3 Mass ELISA Kit (Echelon) was used for detection and quantification
following the manufacturer’s instructions.

2.2.7 Western blotting and subcellular fractionation assay
Western blotting and subcellular fractionation assay were performed as previously
described (Fayngerts et al., 2017, 2014). For Western blot estimation of protein levels, cells
were lysed for 15 min at 4°C in RIPA lysis buffer (Sigma) containing 50 mM Tris-HCl
(pH 8.0), 150 mM sodium chloride, 1.0% Igepal CA-630 (NP-40), 0.5% sodium
deoxycholate and 0.1% sodium dodecyl sulfate (SDS), protease inhibitor cocktail (Roche
cOmplete) and phosphatase inhibitors (Roche PhosSTOP). Cell debris was removed by
centrifugation at 14,000g for 15 min at 4°C. In subcellular fractionation experiment,
Qproteome Cell Compartment Kit (Qiagen) was used to separate the membrane and
cytoplasmic proteins according to the manufacturer’s instructions. The protein
concentration of the lysates was measured by BCA Protein Assay Kit (Pierce). Equal
amount of total protein was separated by SDS-PAGE, transferred to PVDF membranes,
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immunoblotted with specific primary and secondary antibodies, and the signals were
revealed by chemiluminescence (Pierce). The following antibodies were used for Western
blotting: anti-GST, Myc, AKT, GSK-3β, p-GSK-3β (S9), cofilin, p-cofilin (S3), pLIMK1(T508)/LIMK2(T505), p-p38 (T180/Y182), ATPase, GAPDH, integrin-β1,
Histone H3 (Cell Signaling Technology), anti-TIPE2 (Proteintech), anti-TNFAIP8
(Proteintech), anti-Flag (Sigma-Aldrich, monoclonal, M2), anti-actin (Sigma-Aldrich,
monoclonal, AC-15), control IgG (Santa Cruz biotechnology), anti-rabbit IgG-HRP (GE
Healthcare Life Sciences NA934) and anti-mouse IgG-HRP (GE Healthcare Life Sciences
NA931). The densitometric quantification of Western blot signals was performed using
ImageStudioLite (LI-COR Biosciences) and ImageJ softwares.

2.2.8 Plasmids and DNA transfection
Full-length murine TIPE2 and human TNFAIP8 isoform b cDNA were generated
by PCR and cloned in frame with a N-terminal GST tag into pRK5 expression vector. Wildtype Cdc42 cDNA was obtained from Addgene and subcloned into pRK5 with Myc tag at
the N-terminus. Cdc42-17N and Cdc42-61L were generated by mutagenesis from wildtype Cdc42 using Stratagene QuikChange II Mutagenesis Kit (Agilent). HEK293T cells
were transfected with plasmid DNA using Fugene 6 reagent (Promega) according to the
manufacturer’s instructions.
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2.2.9 Co-Immunoprecipitation (Co-IP) assay
Immunoprecipitation was performed using Dynabeads protein G (Invitrogen). In
brief, 1.5 mg protein G Dynabeads were coated with 5 μg specific antibodies or IgG control
for 1 h at room temperature with rotation. After removing unbound antibody, the beadantibody complex was incubated with 500 μL cell lysates for 4 h at 4°C with gentle rotation.
The captured Dynabead-Ab-Ag complex was washed four times with PBS and boiled in
2× Laemmli sample buffer. The eluted proteins were fractionated by SDS-PAGE and
detected by Western blot.

2.2.10 GST pull-down assay
Briefly, the cells were transfected with GST-tagged “bait” protein and “prey”
protein expressing plasmids, lysed and quantified by BCA assay to adjust to 1-5 mg/ml.
The cell lysates with equal total protein amount were incubated with 50 μl prewashed
Glutathione Sepharose 4B (GE Healthcare Life Sciences) in 100 μl GST pull-down buffer
(20 mM Tris, 150 mM NaCl, 2 mM MgCl2, 0.1% NP-40 and 20 μg/ml BSA) for 2 h at 4°C
with gentle rotation. Protein-bound Sepharose was washed 3 times, eluted with glutathione
and boiled in 2× Laemmli sample buffer. Supernatants were subjected to SDS-PAGE and
Western blot analysis.
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2.2.11 Mice
Tnfaip8-/- and Tipe2-/- C57BL/6 mice were produced as previously described (H.
Sun et al., 2008, 2015). The Tnfaip8-/-Tipe2-/- double-knockout (DKO) mice were generated
by crossing Tnfaip8-/- with Tipe2-/- mice. WT C57BL/6 mice were purchased from Jackson
Laboratories.

Mice were housed in the Animal Care Facilities of University of

Pennsylvania under pathogen-free conditions. Animal procedures were all pre-approved
by the Institutional Animal Care and Use Committee of the University of Pennsylvania.
All mice experiments conform to the relevant regulatory standards.

2.2.12 Isolation of splenic CD4+ T cells
CD4+ T cells were purified from spleens using EasySep Mouse CD4+ T Cell
Isolation Kit (STEMCELL) or Invitrogen Negative Selection CD4 Purification Kit
(Waltham, MA) according to manufacturer’s instructions. The purity of CD4+ T cells was
greater than 90%, and the viability was greater than 90% as judged by flow cytometry. The
cells were stimulated with 1 μg/ml anti-CD3 (Clone 2C11, eBioscience) and 1 μg/ml antiCD28 (Clone 37.15, Biolegend) for 2 days, and rested for 2-3 days in complete RPMI
culture medium containing 10% FBS, 1% L-glutamine, 1% Penicillin-Streptomycin and
10 ng/ml IL-2 (Invitrogen).
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2.2.13 Flow cytometric analysis of F-actin cellular levels
WT and T2KO dHL-60s, or T2KO cells re-expressing empty vector or TIPE2 were
rested in assay buffer containing HBSS with Ca2+/Mg2+, 25 mM HEPES and 0.2% HSA.
Cells were treated with or without fMLP (10 nM) for 30, 60, 120 and 300 sec. Cells were
then fixed in PBS containing 4% paraformaldehyde overnight at 4C°, and permeabilized
in PBS containing 0.1% Triton X-100 for 5 min at room temperature. Cells were stained
with control IgG (Santa Cruz Biotechnology) or Phalloidin-AlexaFluor 555 (Thermo
Fisher Scientific) for 1 h at room temperature, and analyzed by flow cytometry. The
experiments were performed in triplicates.
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2.3 Results
2.3.1 Reduced cell proliferation and survival of TNFAIP8-deficient human HL-60
cells generated by CRISPR/cas9
In order to knock out all TNFAIP8 protein isoforms in HL-60 cell line, three
sgRNAs were designed to target the earliest sequences of the shared exon (Figure 1.2).
After cloning into LentiCRISPRv2 vector (Sanjana et al., 2014; Shalem et al., 2014), the
constructs were transfected into Lenti-X 293T cells along with 3rd generation lentiviral
packaging plasmids. Since Mycoplasma would interfere with cell attachment, Lenti-X
293T and HL-60 cells were tested periodically to confirm free of Mycoplasma
contamination (Figure 2.1A). 1.0 μg/mL puromycin was determined to be the lowest
concentration that can result in massive HL-60 cell death in ~3 days, and was used to select
the stable cell line (Figure 2.1B).
To validate the cleavage efficiency of sgRNAs, T7EI genomic cleavage detection
(GCD) assay was performed on the genomic DNA of cells harvested before (Figure 2.1C,
D) and three days after puromycin selection (Figure 2.1E). The single clones were selected
from polyclonal population targeted by sgRNA1 and sgRNA2 (at least eight clones
respectively for each sgRNA) through semi-solid methylcellulose-based medium. After
cell culture expansion, Sanger sequencing was performed in selected single clones to
validate that nucleotide insertion or deletions (indels) in the targeted exon generated
premature stop codons (Figure 2.2A). In addition, Western blot was performed to validate
the complete knockout of TNFAIP8 proteins (Figure 2.2B). These data validated the
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efficiency of TNFAIP8 sgRNAs in the infected cells and the establishment of HL-60 cell
line by CRISPR/cas9.
We observed that TNFAIP8 knockout (TKO) HL-60 cells showed reduced
proliferation in RPMI-1640 medium containing either 10% FBS (Figure 2.3A) or 1% FBS
(Figure 2.3B) relative to WT cells. In addition, counting of cells in 1% FBS medium was
performed with trypan blue exclusion method, and TKO HL-60s showed lower viability
after two days in culture compared to WT cells (Figure 2.3C). These results suggest that
TNFAIP8 knockout can lead to defective HL-60 cell proliferation and survival in vitro.
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Figure 2.1 Transduction of LentiCRISPRv2-sgTNFAIP8 into HL-60 cells,
genomic cleavage validation and puromycin selection
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(A) Lenti-X 293T and HL-60 cells were tested to be Mycoplasma-free. Internal controls
showed a distinct 481 bp band and appeared in each lane, indicating a successfully
performed PCR. The positive control showed a 259 bp band. (B) Puromycin kill curve
of HL-60 using the indicated final concentrations (μg/mL). (C-E) The transduction
efficiency measured by GFP positive cells 48 h post-infection was over 80%. The T7EI
genomic cleavage detection assay was performed on the genomic DNA of cells
harvested before (C, D) and three days after puromycin selection (E). Arrows indicate
digested reannealed PCR products by T7EI (which cleaved mismatched DNA
heteroduplexes).
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Figure 2.2 Validation of CRISPR/cas9-mediated TNFAIP8 gene knockout in HL60 cells
(A, B) Three sgRNAs targeting the earliest sequences of the shared exon of human
TNFAIP8 isoforms were cloned into LentiCRISPRv2 vector. After puromycin selection,
the single clones were derived from semi-solid methylcellulose-based medium for each
sgTNFAIP8 and expanded in culture. Sanger sequencing (A) and Western blot (B) were
performed to validate the indels that generated premature stop codons and truncated
TNFAIP8 proteins.
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Figure 2.3 TNFAIP8 deficiency decreases the proliferation and cell survival of
HL-60 cells in vitro
(A, B) Proliferation of wild-type and TNFAIP8 knockout (TKO) HL-60 cells was
measured by CellTiter-Glo (CTG) assay in RPMI-1640 medium containing 10% FBS
(A) or 1% FBS (B) over the indicated time. (C) Relative viability was measured after
two days culture in 1% FBS containing medium by cell counting with trypan blue. n = 4
(A, B) or n = 8 (C) individual HL-60 WT or TKO clonal cell lines established from
CRISPR/cas9. *P < 0.05; **P < 0.01 (unpaired Student’s t-test). The experiments were
performed three times independently with similar results (mean ± s.e.m.).
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2.3.2 TNFAIP8 deficiency decreases chemotaxis and adhesion of dHL-60
neutrophils in vitro
To investigate whether the deficiency of TNFAIP8 affects chemotaxis in
differentiated HL-60 (dHL-60) neutrophil-like cells, we first tested the chemoattractant
EC50 concentrations as well as concentrations 1-2 logs above and below the expected
EC50 for neutrophils (Carrigan, Weppler, Issekutz, & Stadnyk, 2005; Henkels, Frondorf,
Gonzalez-Mejia, Doseff, & Gomez-Cambronero, 2011; Krause et al., 1985; Millius &
Weiner, 2009; Sai, Walker, Wikswo, & Richmond, 2006; Zahn, Zwirner, Spengler, &
Götze, 1997). The Boyden chambers with 3 μm pore size filters were incubated at 37℃ for
1.5 h, during which chemoattractant gradients were maintained between the compartments.
Among the conditions tested (fMLP 10 nM-100 μM, CXCL8 1-486 nM), 10 nM fMLP
was found to be optimal for dHL-60 migration, with around five to eight-fold cell number
increases through the Transwell filters (Figure 2.4A). CXCL8 induced around two-fold
more chemotaxis within a wide range of concentrations (Figure 2.4B).
To demonstrate if TNFAIP8 is necessary and sufficient in regulating dHL-60
chemotaxis, TNFAIP8 expression was rescued by lentiviral titration and infection into
knockout cell line to equal the endogenous level (Figure 2.5A). We found that TNFAIP8deficient dHL-60 cells display significant defect in transmigration towards both fMLP and
CXCL8, but do not have obvious defect in random migration (without chemoattractant),
relative to that of WT counterparts. These effects were true on either bare Transwell
membranes (Figure 2.5B) or Matrigel coated filters (Figure 2.5C). Furthermore, the
chemotaxis defect can be completely “rescued” by re-expressing a wild-type TNFAIP8
38

transgene (Figure 2.5). These results indicate that TNFAIP8 is essential for the chemotaxis
of human dHL-60 cells in vitro.
To explore if TNFAIP8 knockout affects dHL-60 adhesion, wild-type and TKO
cells were serum starved and subsequently stimulated with fMLP or TNFα before being
placed on surfaces coated with fibronectin or ICAM-1. We found TNFAIP8-deficient dHL60 cells exhibit reduced adhesion to fibronectin (Figure 2.6A, B) or ICAM-1 (Figure 2.6C,
D) coated surfaces compared to their WT counterparts when treated with fMLP (Figure
2.6A, C) or TNFα (Figure 2.6B, D). They didn’t significantly differ when no chemokine
was added. These results indicate that TNFAIP8 knockout confers deficiency in ECM
adhesiveness.
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Figure 2.4 Condition optimization for Transwell migration assay
(A, B) Migration of wild-type dHL-60 cells through 3 μm pore size non-coated
Transwell filters towards various concentrations of fMLP (A) or CXCL8 (B). Data
shown are percentages of cells migrated across the membrane. Data are representative
of two independent experiments with similar results.
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Figure 2.5 TNFAIP8 is required for the chemotaxis of neutrophil-like dHL-60 cells
in vitro
(A) The protein levels of TNFAIP8 and EGFP in wild-type, knockout and lentiviral
rescued TNFAIP8-expressing dHL-60 cells were examined by Western blot. (B, C)
Migration of wild-type and TKO dHL-60 cells on non-coated (A) or Matrigel coated (B)
Transwell filters towards 10 nM fMLP or 3 nM CXCL8. n = 6 clones (B, C). *P < 0.05;
**P < 0.01; ***P < 0.001 (unpaired Student’s t-test). Data are representative of three
independent experiments with similar results (mean ± s.e.m.).
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Figure 2.6 TNFAIP8 promotes dHL-60 adhesion in vitro
(A-D) Wild-type and TKO dHL-60 cells were serum starved for 2 h and subsequently
stimulated with fMLP (100 or 200 nM) (A, C) or TNFα (30 ng/mL) (B, D), and plated
on Fibronectin (A, B) or ICAM-1 (C, D) coated surfaces. The average percentage of
adherent cells is calculated relative to unwashed cells that represent 100%. n = 5 clones
(A-C) or n = 6 clones (D). ns, not significant; *P < 0.05; **P < 0.01 (unpaired Student’s
t-test). Data are representative of three independent experiments with similar results
(mean ± s.e.m.).
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2.3.3 TNFAIP8 and TIPE2 subcellular localization in quiescent and CXCL8treated cells
To gain more mechanistic insights on human TIPE proteins, we studied the
subcellular fractionation of proteomic samples from several cancer cell lines by Qproteome
Cell Compartment assay. The cellular components from cytosol, membrane, nuclear and
cytoskeleton were validated by Western blot using antibodies against GAPDH, integrinβ1/ATPase, Histone H3 and β-actin, respectively (Figure 2.7A-D). We found TNFAIP8
protein localizes in the cytoplasm under resting conditions in HL-60 leukemia cell line, U937 lymphoma cell line and NCI-H69 small cell lung carcinoma cell line (Figure 2.7A-C).
Moreover, in dHL-60 neutrophils, increased TIPE2 membrane localization was observed
after CXCL8 treatment and subcellular fractionation (Figure 2.7D).
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Figure 2.7 TNFAIP8 and TIPE2 subcellular localization in quiescent and CXCL8treated cells
(A-C) TNFAIP8 localizes in the cytosol under resting condition in various human cancer
cell lines. The subcellular fractionations of proteomic samples from HL-60
promyelocytic leukemia cell line (A), U-937 lymphoma cell line (B) and NCI-H69 small
cell lung carcinoma cell line (C) were derived by Qproteome Cell Compartment assay
(Qiagen). The cellular components from membrane, cytosol, nuclear and cytoskeleton
were analyzed by Western blot using antibodies to the indicated proteins. (D) Increased
TIPE2 membrane localization in dHL-60 cells after CXCL8 treatment for the indicated
time.
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2.3.4 TNFAIP8 regulates cellular phosphoinositide levels
To test if there are changes in the total phosphoinositide levels in resting and
stimulated dHL-60 cells, protein-lipid overlay assay was performed with GST-GRP1-PH
(specifically

binds

to

PtdIns(3,4,5)P3),

GST-PLCδ-PH

(specifically

binds

to

PtdIns(4,5)P2), and GST-SidC-3C protein (specifically binds to PtdIns(4)P). We observed
significantly increased total levels of PtdIns(3,4,5)P3 and PtdIns(4)P, but reduced
PtdIns(4,5)P2 in TNFAIP8 knockout dHL-60 cells under resting condition (Figure 2.8A,
B). By contrast, the differences diminished after 60 sec fMLP treatment and the cellular
levels of these phosphoinositides became comparable in WT and TKO cells (Figure 2.8A,
B).
Moreover, we observed significant increase in total PtdIns(3,4,5)P3 level in
TNFAIP8 and TIPE2-deficient (DKO) murine splenocytes (Figure 2.9A) and thymocytes
(Figure 2.9B) through protein-lipid overlay assay. Consistently, by a Mass ELISA Assay
(Echelon Biosciences), cellular levels of PtdIns(3,4,5)P3 in DKO splenocytes (Figure 2.9C)
and CD4+ T cells (Figure 2.9D) were found to be 4 to 8-fold higher than wild-type under
resting condition.
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Figure 2.8 Increased total PtdIns(3,4,5)P3 and PtdIns(4)P but reduced
PtdIns(4,5)P2 levels in TNFAIP8-deficient dHL-60 cells under resting condition
(A, B) Cellular levels of PtdIns(3,4,5)P3, PtdIns(4,5)P2 and PtdIns(4)P in wild-type and
TNFAIP8 knockout dHL-60 cells were measured by protein-lipid overlay assay with
GST-GRP1-PH, GST-PLCδ-PH or GST-SidC-3C protein. dHL-60 cells were stimulated
with DMSO vehicle or 10 nM fMLP at 37°C for 60 sec. n = 6 clones (A, B) individual
HL-60 wild-type or TKO clonal cell lines established from CRISPR/cas9. Signal from
unstimulated wild-type dHL-60 cells was set as 1. ns, not significant; *P < 0.05; ***P <
0.001; ****P < 0.0001 (unpaired Student’s t-test). The experiments were performed at
least three times independently with similar results (mean ± s.e.m.).
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Figure 2.9 Increased total PtdIns(3,4,5)P3 level in TNFAIP8 and TIPE2-deficient
murine splenocytes, thymocytes and CD4+ T cells under resting condition
(A, B) Cellular levels of PtdIns(3,4,5)P3 in wild-type and Tnfaip8-/-Tipe2-/- (DKO)
splenocytes (A) or thymocytes (B) were measured by protein-lipid overlay assay with
GST-GRP1-PH protein (3 mice per group). Signal from wild-type cells was set as 1. (C,
D) Cellular levels of PtdIns(3,4,5)P3 in wild-type and DKO splenocytes (C) or CD4+ T
cells (D) were measured by PtdIns(3,4,5)P3 Mass ELISA Kit (Echelon Biosciences) (34 mice per group). *P < 0.05; **P < 0.01; ****P < 0.0001 (unpaired Student’s t-test).
Data represent two independent experiments with similar results (mean ± s.e.m.).
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2.3.5 Regulation of signaling pathways by TIPE family
The severing activity of cofilin is inactivated by LIMK phosphorylation at the Ser3
position. TNFAIP8-deficient HL-60 cells exhibited upregulated phosphorylated cofilin
(S3) and LIMK (LIMK1 T508/LIMK2 T505) signals as determined by Western blot
(Figure 2.10A). By contrast, no differences were observed in the p-GSK-3β (S9) and p-p38
(T180/Y182) MAP kinase pathways between WT and TKO cells (Figure 2.10A). To
further explore the mechanisms by which TNFAIP8 regulates cell migration, we
manipulated the molecular activities using several pharmacological blockers. The
transmigration of both WT and TKO cells could be attenuated markedly by the antagonists
LY-294,002 (PI3K inhibitor), NSC 23766 (selective inhibitor of Rac1-GEF interaction),
Torin1 (mTOR inhibitor XI), InSolution Z62954982 (Rac1 inhibitor II), Y-27632 (ROCK
inhibitor) and FRAX486 (PAK inhibitor). In addition, NSC 23766, InSolution Z62954982,
Y-27632, FRAX486 and Torin1 effectively reduced the difference between WT and TKO
group (Figure 2.10B), suggesting the importance of these molecular pathways in TNFAIP8
regulation of dHL-60 cell migration. Consistently, we observed decreased F-actin
polymerization in TIPE2-deficient dHL-60 neutrophils upon fMLP stimulation (Figure
2.11A). Furthermore, over-expression of wild-type TIPE2 protein in TIPE2 knockout HL60 cells increased F-actin formation compared to the cells infected with empty retroviral
construct (Figure 2.11B), confirming that this F-actin change was caused by TIPE2.
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Figure 2.10 Regulation of signaling pathways by TNFAIP8
(A) Wild-type and TNFAIP8 knockout HL-60 cells were analyzed by Western blot using
antibodies against the indicated proteins. (B) Migration of WT and TKO dHL-60 cells
across 3 μm pore size non-coated Transwell filters towards 10 nM fMLP, with or without
pretreatment with the indicated inhibitors (n = 4 clones). ns, not significant; *P < 0.05;
**P < 0.01 (unpaired Student’s t-test). Data are representative of two independent
experiments with similar results (mean ± s.e.m.).
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A

B

Figure 2.11 Quantitative measurements of the responses of WT and T2KO dHL60 cells to fMLP stimulation
(A-B) Flow cytometric analyses of actin polymerization (F-actin) in WT and T2KO
dHL-60 cells (A), and dHL-60 cells expressing empty retroviral vector (E) or TIPE2 (T2)
(B). Cells were stimulated with fMLP at the indicated time, stained with fluorescent dyeconjugated phalloidin and examined by flow cytometer. *P < 0.05; **P < 0.01 (unpaired
Student’s t-test). The experiments were performed in triplicates and repeated two times
with similar results (mean ± s.d.).
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2.3.6 TIPE family proteins can associate with Cdc42, Cdc42-17N, Par3 and AKT
TIPE2 has been reported to co-immunoprecipitate with Rac in 293T cells or dHL60 cells stimulated with fMLP (Fayngerts et al., 2017). We assessed immunoblot of
TNFAIP8, TIPE2, Cdc42 in 293T cells expressing recombinant GST-tagged
TNFAIP8/TIPE2 and Myc-tagged Cdc42, following immunoprecipitation (IP) with antiGST or the control antibody immunoglobulin (IgG). We found Myc-Cdc42 was able to
immunoprecipitate with GST-TNFAIP8 (Figure 2.12A) or GST-TIPE2 (Figure 2.12B)
when expressed in 293T cells. Additionally, TIPE2 associated with Par3 (Figure 2.12C)
but not Par6 (data not shown) when GST-tagged TIPE2 was expressed and
immunoprecipitated in 293T cells. Furthermore, TIPE2 was found to preferentially
associate with the Cdc42-17N mutant, which is a GDP-bound form of Cdc42, rather than
the Cdc42-61L mutant, which is a GTP-bound form (Figure 2.12D). In addition, IP with
TIPE2 antibody and Western blot for AKT revealed endogenous association of these two
molecules in Raw 264.7 macrophages (Figure 2.12E). These results indicate TIPEs may
function through Rho family of small GTPases such as Rac and Cdc42, as well as PI3KAKT pathway to contribute to actin remodeling in directional migration.
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Figure 2.12 Co-Immunoprecipitation (Co-IP) analysis of TNFAIP8 and TIPE2
with Cdc42, Cdc42-17N, Par3 and AKT
(A-D) Immunoblot analysis of the indicated proteins in 293T cells expressing
recombinant GST-tagged TNFAIP8 (A) or TIPE2 (B-D), and Myc-tagged Cdc42 (A, B)
or Cdc42-17N (D), assessed before (below) or after (above) immunoprecipitation with
anti-GST or the control antibody immunoglobulin (IgG). (E) Lysates of Raw 264.7 cells
were subjected to IP with anti-TIPE2 or control IgG. The precipitates were analyzed by
Western blot using TIPE2- or AKT-specific antibodies. Data represent at least two
independent experiments with similar results.
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2.4 Discussion
In this part of study, we conducted CRISPR/cas9-mediated TNFAIP8 gene
knockout in HL-60 cells. In addition to decreased proliferation and cell survival, we have
observed defective migration and adhesion upon fMLP and cytokine stimulation on various
ECM substrates including fibronectin, Matrigel and ICAM-1 in these differentiated
neutrophil-like cells. As transmigration defect can be caused by either velocity or
directionality, two-dimensional chemotaxis could be further studied in μ-slide chemotaxis
chambers with migratory tracks recorded by time-lapse microscopy. As we have seen some
pharmacological inhibitors affect the migratory difference between WT and TKO dHL60s, it would be interesting to examine if membrane translocation and polarization of
endogenous TNFAIP8 and TIPE2 proteins change after treating with these inhibitors.
We have seen the reductions in the total PtdIns(3,4,5)P3 and PtdIns(4)P levels but
not PtdIns(4,5)P2 in TKO as compared to WT cells, suggesting TNFAIP8 can regulate
phosphoinositide metabolism and signaling. Similar approaches could be employed to test
if TNFAIP8 overexpression could reduce cellular level of PtdIns(3,4,5)P3. Besides proteinlipid overlay assay with PH domains, cellular levels of phosphoinositides could be
examined by immunoblotting (dot blot) with anti-PtdIns(3,4,5)P3/PtdIns(4,5)P2 antibodies,
or through immunofluorescence confocal microscopy. It would be interesting to further
visualize the subcellular changes of PtdIns(3,4,5)P3 and PtdIns(4,5)P2 levels regulated by
TNFAIP8 expression. Wild-type or knockout cells can be infected with PLCδ-PH-GFP or
AKT-PH-GFP/GRP1-PH-GFP as biosensors, treated with or without stimulation, fixed and
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visualized by confocal microscopy. The ratios of signals on plasma membrane over those
in the cytoplasm in the same cell can be quantified based on fluorescence intensity.
NSC 23766, InSolution Z62954982, Y-27632, FRAX486 and Torin1 inhibitors
attenuated dHL-60 migration markedly, and effectively reduced the difference between
WT and TKO cells, indicating that TNFAIP8 may function through Rac and Cdc42 to
contribute to actin remodeling. The degree of overall Rac/Cdc42 activation can be
determined by Pak1 protein-binding domain (PBD) pull-down assay. The localized
activation can be tested by immunofluorescence confocal microscopy using specific
antibodies against p-AKT, Rac-GTP and Cdc42-GTP, as well as the polarization of F-actin.
It would also be interesting to check if TNFAIP8 deficiency reduces the ratio of membranebound versus the cytosolic endogenous Rac, or if TNFAIP8 knockout impairs the binding
of Cdc42 to the Par complex.
The results in this chapter suggest that TIPEs can bind to Rho GTPases to prevent
their activation and maintain the quiescent cellular state. Exposure to chemoattractants
upregulates TIPEs membrane translocation, which can set free the Rho GTPases. The free
activated Rac/Cdc42 can then initiate downstream effector signaling, leading to directional
migration. In the TKO cells, the quiescent state can not be maintained in the absence of
TNFAIP8, which results in constitutively elevated level of PtdIns(3,4,5)P3. Thus, TIPE
family may represent a novel negative regulator of Rho GTPases, similar to the unique
class of Rho GDP-dissociation inhibitors (RhoGDIs).
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CHAPTER 3

TNFAIP8 INTERACTS WITH PHOSPHOINOSITIDES
AND MEDIATES SIGNALING OF
PHOSPHOINOSITIDE-BINDING PROTEINS
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3.1 Introduction
Through protein-lipid overlay assay, we have previously screened the binding of
TIPEs to all eight phosphoinositides and seven other biologically important eukaryotic
lipids including lysophosphatidic acid (LPA), lysophosphocholine (LPC), phosphatidylethanolamine

(PE),

phosphatidylcholine

(PC),

sphingosine-1-phosphate

(S(1)P),

phosphatidic acid (PA) and phosphatidylserine (PS) (Fayngerts et al., 2014). TIPEs were
found to predominantly interact with PtdIns(4,5)P2, PtdIns(3,5)P2, PtdIns(3,4)P2 and
PtdIns(3,4,5)P3, out of the 15 lipids screened. One caveat of lipid strip was that more watersoluble or electronically charged phosphoinositides like PtdIns(3,4,5)P3 could be easier to
wash away. To determine if the screened lipid-protein interactions were also true in the
model lipid bilayer, sedimentation-based binding assays (Kavran et al., 1998; A. Lee &
Lemmon, 2001; Tortorella & London, 1994) have been employed. Additionally, we also
used Surface Plasmon Resonance (SPR) for real-time, label-free detection of these
biomolecular interactions. In principle, the plasmons are generated when polarized light
strikes the gold film at the interface between two media, and the decreased intensity of
reflected light at the resonance angle will be in proportion to the mass on sensor surfaces
(Beseničar, Maček, Lakey, & Anderluh, 2006; Homola, Yee, & Gauglitz, 1999).
Cofilin is a member of the actin depolymerizing factor (ADF)/cofilin family and
functions as an actin-severing protein (Prunier, Prudent, Kapur, Sadoul, & Lafanechère,
2017). By severing and depolymerizing older filaments, cofilin can increase the availability
of filament ends and the actin monomers, thereby promoting newer filamentous actin (Factin) formation. Therefore, cofilin can regulate actin dynamics by enhancing membrane
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protrusion and promoting cell motility in vivo, and is reported to be a key regulator in the
chemotaxis of metastatic cancer cells (Song et al., 2006; van Rheenen, Condeelis, &
Glogauer, 2009; W. Wang, Eddy, & Condeelis, 2007). The activities of cofilin are tightly
controlled through several mechanisms in cells, of which the most well-studied include
phosphorylation and binding to phosphoinositides. Firstly, cofilin can be inactivated by
phosphorylation at serine 3 (Ser3) by LIM kinases (LIMKs) and testis-specific kinases
(TES kinases or TESKs), which are regulated by Rho GTPases (Prunier et al., 2017). Ser3
phosphorylation site locates in the actin-binding domain, which renders cofilin inactive
towards F-actin binding. The dephosphorylation of Ser3 by slingshot homolog (SSH) or
chronophin

(CIN)

phosphatases

circumvents

this

inhibition.

Secondly,

the

dephosphorylated cofilin can still be inhibited by its binding to PtdIns(4,5)P2 (BravoCordero, Magalhaes, Eddy, Hodgson, & Condeelis, 2013; Ghosh et al., 2004). The local
excitation global inhibition (LEGI) mechanism has been proposed for cofilin activation in
polarized cells (Mouneimne et al., 2006; van Rheenen et al., 2009). This mechanism
involves global phosphorylation of cytosolic cofilin resulted from external stimulation
activated LIMK, and the local release and translocation of plasma membrane (PM) cofilin
to the F-actin compartments (active cofilin), resulted from PLC mediated PtdIns(4,5)P2
reduction. In this chapter, we’ll examine the interaction of TNFAIP8 with
phosphoinositides and whether it can mediate signaling of phosphoinositide-binding
proteins.
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3.2 Materials and Methods
3.2.1 DNA constructs
Expression plasmids of human TNFAIP8 isoform b, murine TNFAIP8 isoform 1
and the PH domains from phospholipase C-δ1 (PLCδ-PH) and general receptor for
phosphoinositides (GRP1-PH) were constructed by cloning PCR-amplified cDNA into
pET-SUMO vector (LifeSensors, Malvern, PA), in frame with the N-terminal 6His-SUMO
tag. The mutagenesis was performed using Stratagene QuikChange II Mutagenesis Kit
(Agilent) according to the manufacturer’s instructions. The TIPE2 Entrance mutant was
generated by replacing amino acid residues 28H, 75R, 91R and 183K with glutamine (Q).
The murine TNFAIP8 isoform 1 Entrance mutant was generated by replacing the three
positively charged amino acids H86, R87, K103 positioned at the opening of the
hydrophobic cavity with Q. TNFAIP8 2Q mutant was generated by replacing K41 and K42
in the α0 helix with Q (the corresponding positions in TIPE2 K15,16Q mutant). Two
additional lysines 46 and 50 in the α0 helix were mutated to construct the 4Q mutant. The
lentiviral expression plasmids of TNFAIP8, TIPE2 and mutants were constructed by
cloning the open reading frame of each cDNA into the multiple cloning site of pGL-LUEGFP vector.

3.2.2 Protein purification
Protein purification has taken advantage of the pET-SUMO fusion tag system. In
principle, recombinant 6His-SUMO tagged proteins were expressed from Escherichia coli
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(E. coli) BL21(DE3) and purified using Ni-NTA resin. 6His-SUMO tagged proteins were
eluted from beads, followed by cleavage with SUMO Protease 1. The 6His-SUMO fusion
proteins and 6His tagged SUMO Protease 1 after cleavage were removed by affinity
chromatography on a second Ni-chelating resin. Untagged native proteins were eluted,
separated by SDS-PAGE and stained with Coomassie Blue G-250.
A fresh bacteria colony was inoculated to 10 ml of LB broth containing 200 μg/ml
Ampicillin and 50 μg/ml Chloramphenicol, and grown at 37°C overnight. Use the
overnight seed culture (1:50 dilution) to inoculate 500 ml 2 x YT or Terrific Broth medium,
containing antibiotics and 0.2% glucose. The cells were grown with vigorous shaking at
37°C until an OD600 of around 0.6 (0.5-0.7) was reached. Bacteria double every ~20 min
so it’s important to check the OD600 timely to avoid overgrowing. Optionally take a preinduction sample by spinning down 1 ml of culture and decant the medium. Boil the pellet
in 50 μl 4 x SDS sample buffer and freeze until use. Induce protein expression by adding
250 μl of 1 M Isopropyl β-d-1-thiogalactopyranoside (IPTG) stock to a final concentration
of 0.5 mM, and shake vigorous at 16°C overnight.
The cells were harvested by centrifugation at 4°C, 4,000g for 20 min. All
purification steps afterwards were carried out at 4°C to prevent protein degradation. The
lysis buffer was composed of 50 mM sodium phosphate (NaH2PO4), 300 mM NaCl, 10%
glycerol, 10 mM Imidazole and 0.1% (w/v) CHAPS, and adjusted to pH 7.6. The lysis
buffer was pre-cold, and was added 20 mM 2-Mercaptoethanol (β-ME) and protease
inhibitors (cOmplete mini tablet, EDTA-free, Roche) right before use. The bacteria pellet
was resuspended in 20 ml lysis buffer per 500 ml culture, transferred to 50 ml falcon tubes,
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and added 400 μl 50 mg/ml lysozyme stock to 1 mg/ml final concentration. Incubate on ice
for 30 min during which pipet up and down 4-5 times. Sonicate to disrupt the cells by using
6 x 10 sec bursts at 200-300W with a 10 sec cooling period between each burst. If the lysate
was very viscous, optionally add Benzonase nuclease (Sigma) at the amount of 3 units (U)
per ml of original cell culture volume processed. Alternatively, draw the lysates through
narrow-gauge syringe needles several times. Centrifuge lysates at 10,000 g, 4°C for 20-30
min to pellet the cellular debris. During centrifugation equilibrate the Ni-NTA matrix
(Qiagen) with lysis buffer; 1ml of Ni-NTA slurry (0.5ml bed volume capable of binding
2.5-5 mg protein) was needed per 4 ml cleared lysates. Collect the supernatant and save 20
μl for SDS-PAGE analysis. Add cleared lysates to equilibrated Ni-NTA matrix and mix
gently by shaking (200 rpm on a rotary shaker) at 4°C for 60 min. It’s important to never
vigorously agitate a protein sample: the preferred method of mixing protein solutions was
to gently mix using a micro-pipettor with polypropylene tips, but not larger pipettor with
polystyrene tips; alternatively, for larger solutions gently invert in a 15 to 50 ml capped
polypropylene tube. Also avoid introducing foam or air bubbles as these would denature
proteins. Spin down at 1000g for 1 min to collect the beads. Wash with 12 ml wash buffer
4 times by spinning down at 1000g for 1 min and discard the supernatant. The wash buffer
was composed of 50 mM NaH2PO4, 500 mM NaCl, 10% glycerol and 30 mM Imidazole,
and adjusted to pH 7.6. Elute the protein 4-5 times with 1 ml elution buffer by mixing the
tube well and gently rotating for 2 min at 4°C. The elution buffer was composed of 50 mM
NaH2PO4, 500 mM NaCl, 10% glycerol, 250 mM Imidazole and 0.1% (w/v) CHAPS, and
adjusted to pH 7.6. Take 20 μl of each eluate and the beads for SDS-PAGE analysis. The
eluates were exchanged to SUMO protease buffer using Slide-A-Lyzer cassettes (Thermo
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Fisher Scientific) at 4°C overnight, which was coupled with the cleavage step with SUMO
Protease 1 added. The SUMO protease buffer was composed of 50 mM NaH2PO4, 300 mM
NaCl, 10% glycerol, 0.01% (w/v) CHAPS and 1 mM DTT, and adjusted to pH 7.2. Save
20 μl post-cleavage protein samples for SDS-PAGE analysis. The cut 6His-SUMO tag,
uncut 6His-SUMO fusion proteins and 6His tagged SUMO Protease 1 in the post-cleavage
protein solution were removed by a second round of Ni-NTA affinity chromatography. The
required amount of Ni-NTA agarose needed to capture the 6His-tagged contaminants was
calculated. Ni-NTA resin was equilibrated with SUMO protease buffer, and mixed gently
with dialyzed protein solution. The mixture was incubated for 10 min at 4°C with gentle
rotation, and centrifuged at 1000g for 1 min to pellet the resin. The supernatant and beads
were collected and subjected to SDS-PAGE analysis (Figure 3.1A).
If the protein was to be used the following day, a part of the protein was dialyzed
overnight against 4 L of HBS (25 mM HEPES, 150 mM NaCl, pH 7.4) buffer using SlideA-Lyzer cassettes (Thermo Fisher Scientific). If the protein concentration became too
diluted, Amicon Ultra centrifugal filters (MilliporeSigma) were used to concentrate the
proteins. Final eluates with untagged native proteins were at least 95% pure as judged from
overloaded Coomassie Blue G-250 stained SDS gels (Figure 3.1A, B). Protein
concentrations were determined based on absorbance at 280 nm using calculated extinction
coefficients. For long-term storage, the proteins were dialyzed overnight against 1 L of
Tris-HCl storage buffer. The storage buffer was composed of 50 mM Tris-HCl, 50 mM
NaCl and 25% glycerol (or ethylene glycol), supplemented with 0.02% (w/v) sodium azide
(NaN3, anti-microbial agent), 5 mM TCEP (reducing agent) and 1 mM EDTA (metal
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chelator to avoid metal-induced oxidation of -SH groups and help to maintain the protein
in a reduced state). Based on protein concentration, aliquot single use amount to sterile
Eppendorf (EP) tubes. Snap freeze in liquid nitrogen and store in -80°C freezer. The
thawing process should be rapid and placed on ice as a quick freeze and a quick thaw were
usually the best practices for retaining protein activities (preventing phase partitioning of
the salts/protein). Once thawed, the sample was gently mixed using a micro-pipettor to
make sure the solution was homogeneous. Check the protein solution for cloudiness (if the
protein solution was found to be cloudy upon thawing, the protein bioactivity was likely to
have been adversely affected). Prior to experiments, purified proteins were dialyzed
exhaustively in 4 L HBS buffer at 4°C overnight.
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Figure 3.1 Protein purification of TNFAIP8 using pET-SUMO fusion tag system
(A-B) Recombinant 6His-SUMO tagged TNFAIP8 (A), TIPE2 and mutants (B) were
expressed from Escherichia coli (E. coli) BL21(DE3) and purified using Ni-NTA resin.
6His-SUMO tagged proteins were eluted with 250 mM Imidazole from beads, followed
by cleavage with SUMO Protease 1. The 6His-SUMO fusion proteins and 6His tagged
SUMO Protease 1 after cleavage were removed by affinity chromatography on a second
Ni-chelating resin. Untagged native proteins were eluted, separated by SDS-PAGE and
stained with Coomassie Blue G-250. Purified proteins (A, B) were at least 95% pure
judging from overloaded Coomassie Blue stained SDS gels.
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3.2.3 Phosphoinositide binding assay
Sedimentation-based phosphoinositide binding assays were performed as
previously described (Fayngerts et al., 2017, 2014). Dioleoylphosphatidylcholine (DOPC)
and brominated distearoyl PC (brominated PC) were purchased from Avanti Polar Lipids.
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 were purchased from CellSignals. Purified trypsin
inhibitor of Glycine max (soybean) (Sigma-Aldrich) was used as a control protein. The
following small unilamellar vesicles (SUVs) were used at a concentration of 2 mM (1 mM
available lipids for binding): (i) 10% PtdIns(4,5)P2 + 10% DOPC + 80% brominated PC,
(ii) 10% PtdIns(3,4,5)P3 + 10% DOPC + 80% brominated PC, or (iii) 20% DOPC + 80%
brominated PC. Proteins were used at a concentration of 5 μM. Samples were incubated 1
h at room temperature (RT), and subjected to ultracentrifugation as described (Kavran et
al., 1998; A. Lee & Lemmon, 2001; Tortorella & London, 1994). The relative amount of
proteins in supernatant and pellet was determined by Coomassie Blue G-250 staining of
SDS-PAGE gels containing the resolved proteins.

3.2.4 Phosphoinositide extraction and transfer assays
The small unilamellar vesicles (SUVs) were produced and sedimentation-based
phosphoinositide extraction and transfer assays were performed as previously described
(Fayngerts et al., 2017). Recombinant TNFAIP8, Entrance mutant and PLCδ-PH were
expressed from Escherichia coli BL21(DE3) cells (Agilent) and purified using Ni-NTA
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Agarose (Qiagen). For the sedimentation-based PtdIns(4,5)P2 extraction assay, 100 μM
SUVs composed of 10% BODIPY FL PtdIns(4,5)P2 in DOPC background with or without
10% unlabeled PtdIns(4,5)P2 or PtdIns(3,4,5)P3 were mixed with 10 μM purified trypsin
inhibitor, PLCδ-PH or TNFAIP8, incubated for 1 h at room temperature, and centrifuged
as described (Kavran et al., 1998; A. Lee & Lemmon, 2001). In sedimentation-based PC
extraction assay, 100 μM SUVs composed of 10% BODIPY FL PC with 10% unlabeled
PtdIns(3,4,5)P3 were mixed with 10 μM purified TNFAIP8 or Entrance mutant, incubated
1 h at room temperature, and centrifuged as described above. The fluorescence intensity of
supernatant (corresponding to BODIPY FL PtdIns(4,5)P2 or BODIPY FL PC extraction)
was detected using Infinite 200 Pro fluorescence plate reader (Tecan). In sedimentationbased PtdIns(4,5)P2 transfer assay, supernatant generated in TNFAIP8 sedimentationbased PtdIns(4,5)P2 extraction assay was mixed with 500 μM 100% PC SUVs or HBS
buffer alone, incubated for 1 h at room temperature, and centrifuged as described. The
fluorescence intensity of supernatant (corresponding to soluble TNFAIP8-BODIPY FL
PtdIns(4,5)P2) was detected as above.

3.2.5 Surface Plasmon Resonance (SPR) assay
SPR assays were carried out using a BIAcore T200 instrument (GE Healthcare).
Briefly, the surface of L1 sensor chip was cleaned by a 5 min injection of 40 mM octyl Dglucoside at a flow rate of 5 μl/min. Vesicles containing DOPC alone, 3% or 10%
(mole/mole) of PtdIns(4,5)P2 or PtdIns(3,4,5)P3 were generated through 50 nm NanoSizer
Liposome Extruders (T&T Scientific). Vesicles were immobilized on L1 sensor chip
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surface, resulting in a signal of around 6500 to 8500 resonance units (RUs). Purified test
proteins were injected over the surface at five or more sequentially diluted concentrations,
at a flow rate of 3 μl/min. All experiments were performed at 25◦C in HBS buffer (pH 7.4).
The sensorgrams were recorded during the association and disassociation, and were
analyzed using BIAevaluation software (GE Healthcare). SPR signals were corrected for
background (DOPC) binding, and a binding isotherm was generated from equilibrium
response (Req) versus the concentration (C) of proteins. The equilibrium dissociation
constant (KD) was derived from steady-state affinity analysis by nonlinear least-squares
fitting of the binding isotherm using the equation Req=Rmax/(1+KD/C). The percentage of
maximal binding was determined at each protein concentration as equilibrium response
divided by the maximum response measured at saturation.

3.2.6 PI3K enzymatic assay
PI3K-mediated phosphorylation of PtdIns(4,5)P2 was measured by determining
ATP consumption using the ADP-Glo Lipid Kinase Assay Kit (Promega) according to the
manufacturer’s instructions. Reaction buffer consisted of 0.4 nM PI3K (p110α/p85α), 50
μM phosphatidylserine + PtdIns(4,5)P2 (at 3:1 ratio), 25 μM ATP, and different
concentrations of TNFAIP8 protein. 2 μM BSA was used as a negative control protein.
Control experiment without phospholipid substrates showed only background level of ATP
consumption. PI3K-catalyzed generation of PtdIns(3,4,5)P3 was determined at 60 min after
reaction initiation, and the value in the absence of TNFAIP8 protein was set to 1.
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3.2.7 F-actin depolymerization assay
Small unilamellar vesicles (SUVs) were produced as described (Fayngerts et al.,
2017; Kavran et al., 1998; A. Lee & Lemmon, 2001). Actin Polymerization Biochem Kit
(Cytoskeleton) was used to investigate F-actin depolymerization by cofilin in the absence
or presence of control protein BSA, TNFAIP8, TIPE2, and SUVs containing 10%
PtdIns(4,5)P2, 10% PtdIns(3,4,5)P3 or 10% PtdIns(4,5)P2 plus 10% PtdIns(3,4,5)P3,
according to the manufacturer’s protocol with minor modifications. 2 mM SUVs (1 mM
total available lipids) were pretreated with 11 μM control protein BSA or TNFAIP8/TIPE2
protein for 1 h; then 11 μM cofilin was added to each reaction and incubated for 20 min.
In addition, 11 μM cofilin was also incubated with 11 μM TIPE2 or BSA for 20 min
(control reactions). Pyrene-labeled F-actin stock was diluted with General Actin Buffer
containing 25 mM Tris-HCl (pH 8.0) and 0.2 mM CaCl2 to the concentration of 0.1 mg/ml.
For each sample, 100 μl of diluted pyrene-labeled F-actin stock was used. The fluorescence
signals were detected by Infinite 200 Pro fluorescence plate reader (Tecan). The
fluorescence were measured immediately before and after adding 10 μl of one of the
following reagents: (a) BSA (22 μM), (b) cofilin (11 μM) + BSA (11 μM), (c) cofilin (11
μM) + TNFAIP8/TIPE2 (11 μM), (d) cofilin (11 μM) + BSA (11 μM) + SUVs, (e) cofilin
(11 μM) + TNFAIP8/TIPE2 (11 μM) + SUVs, or (f) vehicle (i.e., 25 mM HEPES, 150 mM
NaCl, pH 7.5). The experiments were performed in duplicates or triplicates. The
fluorescence measurements of each sample before adding the above reagents were set as
100%. The curves were fitted to one-phase exponential decay equations (GraphPad Prism)
to assess the degree/span of F-actin depolymerization, which was calculated as differences
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in fluorescence before and after adding the above reagents for each sample. Additionally,
results were also presented as the differences in the remaining F-actin over a period of time.
TNFAIP8 or TIPE2 alone did not affect F-actin depolymerization, which was not shown.

3.2.8 Re-expression of proteins in knockout cells by lentivirus infection
Expression constructs were transfected into Lenti-X 293T cells (Clontech) using
Lipofectamine 3000 reagent (Thermo Fisher Scientific) following the manufacturer’s
protocol. Lentivirus was produced by co-transfecting pGL-LU-TNFAIP8/TIPE2-EGFP,
pGL-LU-mutants-EGFP or FUGW expression vectors with 3rd generation lentiviral
packaging plasmids (pRSV-Rev, pCMV-VSV-G, and pMDLg/pRRE). Two batches of
lentivirus-containing medium were harvested 24 h and 52 h after transfection, followed by
filtering through a 0.45 μm Steriflip PVDF membrane (MilliporeSigma). Lentivirus was
concentrated 100-fold using Lenti-X Concentrator (Clontech), and titrated by RT-qPCR
Titration Kit (Clontech) as well as EGFP-positive cell counts. Transduction was performed
by incubating cells with medium containing the lentivirus at a multiplicity of infection
(MOI) of 10-100 in the presence of 4 μg/ml Polybrene (Sigma) for 12-24 h. The amount
of lentivirus used was titrated and adjusted to ensure the levels of overexpressed proteins
were similar to the endogenous levels in HL-60 cells or murine CD4+ T cells. Cells were
allowed to recover in complete medium for 24 h and then isolated by fluorescence activated
cell sorting (FACS) before being used for experiments.
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3.2.9 Transmigration assay of CD4+ T cells
CD4+ T cells were purified from mouse spleens using Invitrogen negative selection
beads, and stimulated with 1 μg/ml anti-CD3 (Clone 2C11, eBioscience) and 1 μg/ml antiCD28 (Clone 37.15, Biolegend) for 2 days. The cells were rested for 2-3 days in complete
RPMI culture medium containing 10% FBS, 1% L-glutamine, 1% Penicillin-Streptomycin,
and 10 ng/ml IL-2 (Invitrogen). The chemotaxis assay was performed using 96-well Neuro
Probe ChemoTx Transwell with 3 μm pore size (Neuro Probe) according to manufacturer’s
protocol. Briefly, the bottom wells were filled with 30 μl of assay buffer with or without
100 ng/ml CCL21, and CD4+ T cells were added to the upper wells pre-coated with 15
μg/ml Fibronectin (Sigma). After incubation at 37°C for 1 h, migrated cells collected from
the bottom wells were quantified using a cell counter. For migration assay with CD4+ T
cells expressing TIPE2 or TIPE2 Entrance mutant, DKO CD4+ T cells were electroporated
using the cell-type specific Nucleofector Kit (Lonza), with TIPE2- or Entrance mutantexpressing plasmid 24 h before the migration assay.
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3.3 Results
3.3.1 TNFAIP8 interacts with phosphoinositides and can act as a transfer protein
of lipid second messengers
For more quantitative biochemistry assays, the purification of TNFAIP8 and other
proteins was optimized using Ni-chelating affinity chromatography (Figure 3.2A). The
protein quality and frozen storage procedure were assessed by dynamic light scattering
(DLS). Purified proteins were dialyzed in Tris buffer containing 25% glycerol and were
flash frozen. After thawing and dialysis in HBS buffer, the size distribution of the
hydrodynamics radius of molecules in solution was measured by DynaPro NanoStar
instrument (Figure 3.2B). A single, narrow peak at a size corresponding to the TNFAIP8
protein suggests it stable as monomer (Figure 3.2B).
TIPE family has been shown to predominantly interact with PtdIns(3,4)P2,
PtdIns(3,5)P2, PtdIns(4,5)P2 and PtdIns(3,4,5)P3 through protein-lipid overlay assay
(Fayngerts et al., 2014). To determine if this lipid-protein interaction is also true in the
model lipid bilayer, a sedimentation-based binding assay (Kavran et al., 1998; A. Lee &
Lemmon, 2001; Tortorella & London, 1994) was done by mixing purified TNFAIP8
protein with small unilamellar vesicles (SUVs). If the protein binds to these liposomes,
which can be precipitated by ultracentrifuge, it would be detected in the pellet fraction
rather than in the supernatant. These SUVs were made to contain 10% PtdIns(4,5)P2 or
10% PtdIns(3,4,5)P3 in a phosphatidylcholine (PC) background. We found TNFAIP8
protein sediment efficiently with SUVs containing 10% phosphoinositides. By contrast,
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only background level sedimented with 100% PC, and a negative control protein trypsin
inhibitor exhibited no binding to either type of vesicles (Figure 3.3A).
Next, we used Surface Plasmon Resonance (SPR) for real-time, label-free detection
of biomolecular interactions (Beseničar et al., 2006; Homola et al., 1999). Supported lipid
bilayer was immobilized on a L1 chip by flowing 50 nm extruded SUVs containing DOPC
and 3 or 10 mol% of PtdIns(4,5)P2 (Figure 3.3B) or PtdIns(4,5)P3 (Figure 3.3C). The
steady-state equilibrium dissociation constants (KD) of human TNFAIP8 isoform b protein
to PtdIns(4,5)P2 and PtdIns(3,4,5)P3 were 3.16 and 4.06 μM, respectively (Figure 3.3B,
C), suggesting that TNFAIP8 bound to these lipids with medium affinities.
TIPE2 has been reported to be a carrier protein of both PtdIns(4,5)P2 and PtdIns(3，
4,5)P3 (Fayngerts et al., 2017), but whether TNFAIP8 can act on these lipid second
messengers is unknown. Phosphoinositide-extraction assay showed that when TNFAIP8
was incubated for 1 h with 100 μM vesicles containing 10% BODIPY FL PtdIns(4,5)P2
and 10% PtdIns(3,4,5)P3, increased amount of BODIPY FL PtdIns(4,5)P2 fluorescence
was detected in the supernatant after ultracentrifugation, whereas equivalent experiments
with trypsin inhibitor or PLCδ-PH domain showed no significant fluorescence in the
supernatant (Figure 3.4A). This result suggests that TNFAIP8 can effectively remove
fluorescence labeled PtdIns(4,5)P2 from the SUVs and solubilize it in the supernatant. In
addition, the ability of extraction was compromised by the TNFAIP8 Entrance mutant
(with H86, R87, K103 laying in the opening of the hydrophobic cavity mutated to Qs)
(Figure 3.4B). It is important to note that this was specific to BODIPY FL PtdIns(4,5)P2
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vesicles, as neither TNFAIP8 nor Entrance mutant was able to extract BODIPY FL PC
from 100 μM vesicles containing 20% BODIPY FL PC as control (Figure 3.4B).
To explore if TNFAIP8 was capable of inserting extracted PtdIns(4,5)P2 into a lipid
bilayer, we analyzed the transfer of BODIPY FL PtdIns(4,5)P2 from the soluble TNFAIP8/
BODIPY FL PtdIns(4,5)P2 complexes detected in the supernatant in Figure 3.4A to 100%
PC vesicles. We collected supernatant from the mixture of TNFAIP8 with 100 μM
BODIPY

FL

PtdIns(4,5)P2-containing

vesicles

that

had

been

subjected

to

ultracentrifugation, and incubated them with vesicles containing 500 μM 100% PC for 1 h.
The mixture was then recentrifuged, and the level of BODIPY FL PtdIns(4,5)P2
fluorescence remaining in the supernatant was measured. Addition of 100% PC vesicles
led to a substantial decrease in fluorescence (corresponding to the presumed
TNFAIP8/BODIPY FL PtdIns(4,5)P2 complexes in the supernatant) (Figure 3.4C). The
concomitant loss of BODIPY FL PtdIns(4,5)P2-derived fluorescence from the supernatant
was not accompanied by changes in TNFAIP8 protein concentrations in the supernatant
(Figure 3.4D), suggesting that TNFAIP8 had transferred the BODIPY FL PtdIns(4,5)P2 to
the PC vesicles.
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Figure 3.2 Protein purification and frozen storage assessed by dynamic light
scattering (DLS)
(A) Recombinant 6His-SUMO tagged TNFAIP8, PH domains and 6His-cofilin were
purified from BL21(DE3) E. coli using Ni-NTA resin and were at least 95% pure judging
from overloaded Coomassie Blue stained SDS gels. (B) Purified TNFAIP8 protein was
dialyzed in Tris buffer containing 25% glycerol and was flash frozen. After thawing and
dialysis in HBS buffer, the size distribution of the hydrodynamics radius of molecules in
solution was measured by DynaPro NanoStar (Wyatt Technology). Data represent at
least three independent experiments with similar results.
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Figure 3.3 TNFAIP8 can bind to PtdIns(4,5)P2 and PtdIns(3,4,5)P3 present in small
unilamellar vesicles (SUVs)
(A) Sedimentation-based phosphoinositide binding assay showing the proportion of TNFAIP8
and control protein trypsin inhibitor bound to SUVs containing 100% PC, 10% PtdIns(4,5)P2 or
10% PtdIns(3,4,5)P3. (B, C) SPR analysis of TNFAIP8 binding to DOPC membranes containing
10% (mole/mole) PtdIns(4,5)P2 (B) or PtdIns(3,4,5)P3 (C) on L1 sensor chip. Purified PLCδ-PH
and GRP1-PH domains were used as positive controls, and trypsin inhibitor as a negative control.
The percentage of maximal binding (left panel) and equilibrium KD (right panel) are shown.
***P < 0.001 (Student’s t-test (A)). The values are mean ± s.d. (A-C). Data are pooled from four
(A) independent experiments, or represent three (B, C) independent experiments.
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(grid beneath plot), in the presence of trypsin inhibitor (Control), PLCδ-PH or TNFAIP8
(key). FIU, fluorescence intensity units. (B) Phosphoinositide-extraction assay was used
to determine the percentages of BODIPY FL PtdIns(4,5)P2 extracted from 100 μM 20%
BODIPY FL PtdIns(4,5)P2 vesicles and the percentages of BODIPY FL PC extracted
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3.3.2 TIPE family can regulate PtdIns(4,5)P2-dependent signaling and actin
remodeling through phosphoinositide-binding proteins
To further investigate the actions of TNFAIP8 at the leading edge, we studied the
functional significance of TNFAIP8 interactions to phosphoinositides. TIPE2 has been
reported to be able to act as an “enhancer” for PI3Ks (Fayngerts et al., 2017). To determine
if TNFAIP8 could also promote the activity of PI3Ks, an ADP-Glo PI3K assay was
performed with increasing concentrations of TNFAIP8 protein or 2 μM BSA as control.
Addition of TNFAIP8 to the PI3K (p110α/p85α) significantly potentiated PtdIns(3,4,5)P3
generation in a dose-dependent manner (Figure 3.5). The protein concentration needed to
increase PI3K activity by 2-fold was estimated to be in the range of 500-600 nM (Figure
3.5).
To understand the impact of TNFAIP8 binding to phosphoinositides on cofilin
activity, we tested cofilin-mediated F-actin depolymerization in the presence or absence of
purified TNFAIP8 and phosphoinositides. SUVs containing either PtdIns(4,5)P2 or
PtdIns(4,5)P2 plus PtdIns(3,4,5)P3 significantly decreased cofilin-induced F-actin
depolymerization (Figure 3.6). TNFAIP8 could best rescue the reduction in F-actin
depolymerization caused by SUVs containing both PtdIns(4,5)P2 and PtdIns(3,4,5)P3,
while TNFAIP8 or control protein alone had no effect on F-actin depolymerization (Figure
3.6). These results indicate that the ability of TNFAIP8 to interact with phosphoinositides
impacts cofilin-induced F-actin remodeling. Consistently, TIPE2 showed similar effects
by this actin depolymerization biochemistry assay (Figure 3.7), suggesting that TIPE
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family could regulate phosphoinositide-dependent signaling at the leading edge of
migratory cells.

78

Generation of
PtdIns(3,4,5)P3

A
20

Control
TNFAIP8

10
0

101
102
103
104
Concentration (nM)

Figure 3.5 The effects of TNFAIP8 on PtdIns(3,4,5)P3 generation by PI3Ks
(A) Phosphorylation of PtdIns(4,5)P2 by PI3Ks as measured in the ADP-Glo kinase
assay, in the presence of increasing concentrations of TNFAIP8 protein or 2 μM BSA
(Control). Data represent mean ± s.e.m. of two independent experiments done in
duplicates.
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Figure 3.6 The effect of the interaction of TNFAIP8
with phosphoinositides on
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cofilin-dependent depolymerization of F-actin
(A-C) Representative time course of cofilin-dependent F-actin depolymerization
performed in the presence or absence of control protein (A-C), TNFAIP8 (A-C), small
unilamellar vesicles (SUVs) containing 10% PtdIns(4,5)P2/10% PtdIns(3,4,5)P3 (A), 10%
PtdIns(4,5)P2 (B) or 100% PC (C). Data is shown as the difference in pyrene labeled Factin fluorescence intensity units (FIU) over the indicated time. (D) Quantification of
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Figure 3.7 The effect of TIPE2 binding to phosphoinositides on cofilin-dependent
F-actin depolymerization
(A) Time course of cofilin-dependent F-actin depolymerization performed in the
presence or absence of control protein, TIPE2, SUV containing 10% PtdIns(4,5)P2/10%
PtdIns(3,4,5)P3 (left panel), SUV containing 10% PtdIns(4,5)P2 (middle panel) or SUV
containing 10% PtdIns(3,4,5)P3 (right panel). Results are shown as the difference in the
remaining F-actin over the indicated time between samples containing control protein
and samples containing control protein + SUV or TIPE2 + SUV. (B) The degree of
cofilin-dependent F-actin depolymerization in the presence of control protein, control
protein + SUV, or TIPE2 + SUV was analyzed as described above. FIU, fluorescence
intensity units. ns, not significant; *P < 0.05; **P < 0.01 (unpaired Student’s t-test). The
experiments were repeated three times (mean ± s.e.m.).
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3.3.3 TH domain and α0 helix of TNFAIP8 are important for its phosphoinositides
interactions
The high-resolution crystal structures of murine Tnfaip8 C165S mutant, human
TIPE2 and human TIPE3 have recently been resolved (Fayngerts et al., 2014; J.-S. Kim et
al., 2017; D. Lee et al., 2014; X. Zhang et al., 2008), and they reveal a conserved TIPE
homology (TH) domain composed of a large hydrophobic central cavity. To test the
importance of the hydrophobic pocket in lipid binding capacity, we compared the protein
topographies of these crystal structures. CASTp 3.0 program analytically identifies and
measures the surface accessible pockets as well as interior inaccessible cavities for proteins
and other molecules (A. Binkowski et al., 2006; T. A. Binkowski, Naghibzadeh, & Liang,
2003; C. Chen, Tian, Lei, Liang, & Zhao, 2018). The area and volume of the cavity of
murine Tnfaip8 C165S mutant is 580 and 406 SA (solvent accessible surface, or Richards'
surface), respectively (Figure 3.8A). The 41 wall residues comprising the cavity were
shown in the stick model and highlighted in blue in the sequence annotation panel (Figure
3.8A). Among them, three positively charged amino acids H86, R87, K103 (highlighted in
purple rectangles, Figure 3.8A) lay in the opening of the cavity and were mutated to Qs for
TNFAIP8 Entrance mutation. The 31 hydrophobic amino acids comprising the pocket of
murine Tnfaip8 C165S mutant were compared to all wall residues of human TIPE2 and
human TIPE3 cavities, and identical or similar amino acids in the corresponding positions
were identified and indicated (Figure 3.8B). Four representative conserved amino acids
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L44 (α1 helix), L65(α2 helix), L99(α3 helix), L158 (α5 helix) were selected to mutate to
the much bulkier Ws for Hydrophobic Pocket mutation.
It has been shown previously that the positively charged residues of α0 helix of
TIPE2 protein contributed to its interaction with phosphoinositides, and may function as a
flexible lid of the cavity (Fayngerts et al., 2017). We generated murine TNFAIP8 isoform
1 2Q (K41,42Q) mutant, in which lysines 41 and 42 in the α0 helix were replaced with
glutamines (the corresponding positions in TIPE2 K15,16Q mutant). We also mutated two
additional lysines 46 and 50 in the α0 helix to construct the 4Q mutant (Figure 3.9A). We
constructed all the mutants to pET-SUMO and expressed in BL21(DE3) E. coli, and found
TNFAIP8 L44W, L65W and L99W mutant were expressed at much lower levels judging
from crude lysates (data not shown) and 1st elution, compared to TNFAIP8 2Q, 4Q,
Entrance and L158W mutant, which led to impure protein after 2nd elution using SUMO
fusion tag system (Figure 3.9A). These results indicate that the hydrophobic cavity formed
by TH domain is important for the structural integrity/stability of TNFAIP8 protein.
TNFAIP8 4Q, Entrance and L158W mutant were successfully purified, and were used for
subsequent experiments (Figure 3.9B).
Through protein-lipid overlay assay, binding of purified 6His-SUMO tagged
TNFAIP8, 4Q, Entrance, and L158W mutant proteins to lipids spotted on strips was
determined by immunoblot using antibody against 6His-tag (Figure 3.10A). Consistently,
we found TNFAIP8 predominantly interact with PtdIns(4,5)P2 and PtdIns(3,4,5)P3 out of
the five lipids spotted (Figure 3.10A). TNFAIP8 4Q and Entrance mutant exhibited marked
reductions in phosphoinositides binding, while L158W mutation almost abolished the
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ability to bind phosphoinositides (Figure 3.10A, B). On a L1 SPR sensor chip, we found
murine TNFAIP8 isoform 1 protein exhibit a steady-state KD of 4.06 μM and 3.80 μM to
PtdIns(4,5)P2 and PtdIns(3,4,5)P3, respectively (Figure 3.11 and Table 4). The TNFAIP8
4Q, Entrance and L158W mutant compromised the binding affinity by 3 to 7-fold (Figure
3.11 and Table 4). These results indicate that α0 helix and TH domain are important for
the ability of TNFAIP8 protein to recognize and interact with PtdIns(4,5)P2 and
PtdIns(3,4,5)P3 present in lipid bilayers.
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Figure 3.8 Structural analysis and mutagenesis of TNFAIP8 protein
(A) Protein topography of the crystal structure of murine Tnfaip8 C165S mutant was
analyzed by CASTp 3.0. The wall residues comprising the pocket (red) were shown in
the stick model (in the graph) and highlighted in blue (in the sequence annotation panel).
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at the opening of the cavity. (B) Protein topography of the crystal structures of murine
Tnfaip8 C165S, human TIPE2, human TIPE3 were compared by CASTp 3.0. The 31
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hydrophobic amino acids out of all the wall residues comprising the pocket of murine
Tnfaip8 C165S mutant were listed. Identical (represented by circles) or similar amino
acids in the corresponding positions of human TIPE2 and TIPE3 were indicated. Four
representative conserved amino acids L44 (α1), L65(α2), L99(α3), L158 (α5) were
selected to mutate to Ws for Hydrophobic Pocket mutation.
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Figure 3.9 Expression and purification of TNFAIP8 mutant proteins
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(A) TNFAIP8 L44W, L65W and L99W mutant were expressed at much lower levels
compared to TNFAIP8 2Q, 4Q, Entrance and L158W mutant, which led to impure
protein after 2nd elution using pET-SUMO fusion tag system. (B) TNFAIP8 4Q, Entrance
and L158W mutant were purified from BL21(DE3) E. coli using Ni-NTA resin and were
at least 95% pure judging from overloaded Coomassie Blue stained SDS gels.
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Figure 3.10 TNFAIP8 interacts with phosphoinositides through its TH domain
(A, B) Binding of purified 6His-SUMO tagged TNFAIP8, TNFAIP8 4Q, TNFAIP8
Entrance, and TNFAIP8 L158W mutant proteins to lipids spotted on strips by proteinlipid overlay assay. Immunoblot was performed using antibody against 6His-tag. Signal
from wild-type TNFAIP8 was set as 1. *P < 0.05; **P < 0.01; ***P < 0.001 (unpaired
Student’s t-test). Data represent mean ± s.e.m. of three independent experiments.
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Figure 3.11 SPR analysis of TNFAIP8 mutants
(A, B) SPR analysis of the binding of murine TNFAIP8 isoform 1 and the indicated
mutants to DOPC membranes containing 3% (mole/mole) PtdIns(4,5)P2 (A) or
PtdIns(3,4,5)P3 (B) on L1 sensor chip. Purified PLCδ-PH and GRP1-PH domains were
used as positive controls, and trypsin inhibitor as a negative control (Control). Data are
representative of three independent experiments with similar results.
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Table 4
Kinetics and affinity parameters for binding of TNFAIP8 and mutants to
supported lipid bilayers containing PtdIns(4,5)P2 and PtdIns(3,4,5)P3 measured by
Surface Plasmon Resonance (SPR)
A supported lipid bilayer was generated on L1 sensor chip by flowing extruded SUVs
containing DOPC and 3% (mole/mole) of PtdIns(4,5)P2 or PtdIns(3,4,5)P3. Sequential
dilutions of the indicated proteins were injected over the surfaces, and the association
and disassociation were monitored and measured as described in Materials and Methods
section. ka, association rate constant; kd, dissociation rate constant; KD, equilibrium
dissociation constant. Data are mean ± s.d. from three independent experiments.

PtdIns

Protein

Steady-state KD (µM)

ka (M-1s-1)

kd (s-1)

PtdIns(4,5)P2

TNFAIP8

4.06 ± 0.93

(1.13 ± 0.12) × 103

(8.94 ± 0.13) × 10-3

Entrance Mutant

11.6 ± 3.0

(1.05 ± 0.39) × 103

(8.24 ± 1.77) × 10-3

4Q Mutant

25.7 ± 13.1

(6.25 ± 3.11) × 102

(2.89 ± 1.47) × 10-3

L158W Mutant

30.2 ± 16.3

(3.37 ± 6.00) ×

102

(2.20 ± 2.22) × 10-3

PtdIns(3,4,5)P3

Trypsin inhibitor

>100

nb

nb

PLCd-PH

2.47 ± 1.33

(1.42 ± 1.50) × 104

(8.45 ± 1.10) × 10-3

TNFAIP8

3.80 ± 0.20

(1.36 ± 0.46) × 103

(7.26 ± 0.44) × 10-3

Entrance Mutant

13.2 ± 2.9

(6.71 ± 2.11) × 102

(7.79 ± 2.15) × 10-3

4Q Mutant

16.6 ± 2.0

(6.55 ± 4.20) × 102

(7.86 ± 3.96) × 10-3

L158W Mutant

20.6 ± 1.8

(3.36 ± 0.72) ×

102

(4.13 ± 3.00) × 10-3

Trypsin inhibitor

>100

nb

nb

GRP1-PH

1.95 ± 1.49

(6.02 ± 7.12) × 104

(6.08 ± 1.14) × 10-3
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3.3.4 TNFAIP8-phosphoinositides interactions are important for the cellular
function of TNFAIP8
To further characterize if disrupting these TNFAIP8-phosphoinositides interactions
would affect cellular function and signaling, we constructed TNFAIP8 WT, 2Q, 4Q,
Entrance, L44W, L65W, L99W and L158W mutant into pGL-LU-EGFP lentiviral vector
and re-expressed them in HL-60 TKO cell line (Figure 3.12). It has been shown previously
that the migration defect of dHL-60s was able to be rescued by re-introducing a wild-type
human TNFAIP8 isoform b transgene (Figure 2.5). We found that the chemotaxis defect
of dHL-60 cells could be partially rescued by expressing TNFAIP8 2Q, 4Q or Entrance
mutant transgene, while the expression of L44W, L65W, L99W and L158W mutant failed
to upregulate the transmigration towards fMLP (Figure 3.13A). Consistent with dHL-60
cells, the transmigration defect of murine DKO CD4+ T cells could be rescued by reexpressing wild-type TIPE2, but not by TIPE2 Entrance mutant that had reduced ability to
bind phosphoinositides (the TIPE2 Entrance mutant had its 28H, 75R, 91R and 183K
amino acid residues replaced by Q) (Figure 3.13B).
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Figure 3.12 Transduction of lentiviral vectors expressing TNFAIP8 mutants into
HL-60 cells
(A) The TNFAIP8 WT, 2Q, 4Q, Entrance, L44W, L65W, L99W and L158W mutant
were constructed into pGL-LU-EGFP lentiviral vector and re-expressed in HL-60 TKO
cell line. The lysates were analyzed by Western blot using TNFAIP8 polyclonal antibody
and EGFP antibody. Actin served as a loading control.
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Figure 3.13 TNFAIP8 and TIPE2 mutants deficient in phosphoinositide
interactions have diminished effects on promoting chemotaxis
(A) Transwell migration assay of dHL-60 TKO cells expressing TNFAIP8 mutants from
lentiviral vectors (n = 3 biologically independent samples). Data are representative of
three independent experiments from two clonal cell lines with similar results (mean ±
s.e.m.). (B) Transmigration of DKO mouse CD4+ T cells re-expressing TIPE2 or TIPE2
Entrance mutant (TIPE2mt) (n = 8 per group), as determined by the Transwell assay with
CCL21. Data are pooled from three experiments (B). Values are mean ± s.e.m.
of n biologically independent samples. *P < 0.05; **P < 0.01; ****P < 0.0001 (unpaired
Student’s t-test).
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3.4 Discussion
In this part of study, we have optimized the purification procedures of TNFAIP8
and other proteins from E. coli for more quantitative investigations. The protein quality
and long-term storage condition were validated through the size distribution of the
hydrodynamics radius of molecules in solution by dynamic light scattering (DLS). We
confirmed TNFAIP8 protein interacts with PtdIns(4,5)P2 and PtdIns(3,4,5)P3 present in
lipid bilayers using the sedimentation-based binding assay and SPR analysis. The results
further supported the hypothesis that the α0 helix of TNFAIP8 can function as a flexible
lid of the hydrophobic cavity (Fayngerts et al., 2014; Schaaf et al., 2008), and the
conformational change induced by PtdIns(3,4,5)P3 binding may displace the lid and allow
TNFAIP8 to extract PtdIns(4,5)P2 from the lipid bilayer, solubilize it in the aqueous phase,
and transfer it to the vesicles.
To acquire more mechanistic information, we studied the effects of TNFAIP8 on
mediating the activities of phosphoinositide-binding proteins. We assessed the ability of
TNFAIP8 to promote the phosphorylation of PtdIns(4,5)P2 by PI3K, a key event at the
front lamellipodium. We found that TNFAIP8 protein indeed increased the PI3K-catalyzed
conversion to PtdIns(3,4,5)P3 in a dose-dependent manner in vitro. Besides the
enhancement of PtdIns(4,5)P2-dependent signaling, TNFAIP8 also impacted cofilininduced F-actin remodeling and actin dynamics. These results establish the functional
significance of TNFAIP8 interaction with phosphoinositides, and indicate that TNFAIP8
can function through phosphoinositide second messengers at the leading edge of migratory
cells.
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Finally, mutagenesis analyses were performed to explore the structure and
functional significances of the α0 helix and TIPE homology (TH) domain. To test the
importance of the hydrophobic pocket in lipid binding capacity, we first compared the
protein topographies of the crystal structures of TIPE family. We then replaced leucines
44, 65, 99, 158, which position towards the center of this cavity, with the much bulkier
tryptophan to yield the TNFAIP8 L to W mutants. Same approach has been used to test the
importance of the hydrophobic pockets in orphan nuclear hormone receptors proposed to
bind phosphoinositides (Sablin, Krylova, Fletterick, & Ingraham, 2003). Of the four
Hydrophobic Pocket mutants generated, L158W mutant was able to express at high level
and be successfully purified. This indicates that the hydrophobic cavity formed by TH
domain is important for the structural integrity or stability of TNFAIP8 protein. TNFAIP8
L158W mutant showed markedly diminished ability of phosphoinositides binding, which
is consistent with the structural proposition that the fatty acid chains of phosphoinositides
are positioned inside the TH domain pocket formed by the α1- α6 helixes, while the
negatively charged phosphate head is accommodated by electrostatic interactions with the
positively charged amino acids located at the entrance of the cavity as well as the more
flexible α0 helix. Consistently, TNFAIP8 4Q and Entrance mutant both exhibited
decreased phosphoinositide binding. Supporting these analyses, when re-expressed in TKO
dHL-60 cells, these mutants failed to rescue the migratory defect of TNFAIP8 deficiency.
These studies may help advise in silico drug screening and the development of
pharmaceutical inhibitors targeting TNFAIP8 for its phosphoinositide interaction capacity.

96

CHAPTER 4

TNFAIP8 AND TIPE2 DIRECT MURINE
LYMPHOCYTE MIGRATION

Work of this chapter is from:
Sun, H.*, Lin, M.*, Zamani, A., Goldsmith, J.R., Boggs, A.E., Li, M., Lee, C.N., Chen, X., Li,
X., Li, T., Dorrity, B.L., Li, N., Lou, Y., Shi, S., Wang, W., Chen, Y.H. (2020). The TIPE
Molecular Pilot That Directs Lymphocyte Migration in Health and Inflammation. Scientific
Reports, 10(1), pp.1-13.

*These authors contributed equally to this work

97

4.1 Introduction
Leukocyte migration in response to chemoattractants is essential for immune
homeostasis and inflammation (Bloes et al., 2015; Kunkel & Butcher, 2002). TIPE gene
single nucleotide polymorphisms (SNPs) are associated with the development of several
inflammatory diseases including inflammatory bowel disease (IBD) with pyoderma
gangrenosum (Weizman et al., 2014), multiple sclerosis (Hussman et al., 2016) and plantar
fasciitis (S. K. Kim et al., 2018), as revealed from recent genome-wide association studies
(GWAS). Similarly, TIPE2 regulates both innate and adaptive immunity, and is a risk
factor for IBD, and one of the key driver genes that can cause IBD as revealed from the
“functional genomics predictive network model” of IBD (Peters et al., 2017). TIPE2deficient myeloid cells are hyper-responsive to Toll-like receptor activation and have
enhanced phagocytic and bactericidal activities, and TIPE2-deficient mice are
hypersensitive to intravenously induced septic shock (H. Sun et al., 2008, 2012; Z. Wang
et al., 2012). In this study, we investigated whether TIPE2 and TNFAIP8 play redundant
roles

in

controlling

lymphocyte

migration,

using

experimental

encephalomyelitis (EAE) as a mouse model for neural inflammation.
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autoimmune

4.2 Materials and Methods
4.2.1 Complete blood counts (CBC) and isolation of blood neutrophils (BNs)
Blood was drawn from retro-orbital plexus of the eyes. CBC analysis was
performed on an automated Hemavet FS950 instrument. BNs were isolated using
Histopaque-1119 and Histopaque-1077 (Sigma-Aldrich) according to the manufacturer’s
instructions. The purity of BN populations was greater than 70% as determined by flow
cytometry after staining with anti-Ly6G-APC (eBioscience), and the viability was greater
than 90% as determined by trypan blue staining.

4.2.2 Isolation and enumeration of intestinal IELs
After transcardial perfusion of mice with PBS, Peyer's patches were removed, and
the small intestines were collected and weighed. Intestinal epithelial cells and
intraepithelial lymphocytes were stripped by shaking colonic tissue in PBS that contains
5% FBS, 2 mM EDTA, and 1 mM DTT, for 30 min at 37°C. After filtering through 70
µm cell strainers (BD Biosciences), cells were counted and the total number of cells per
gram of intestinal tissue calculated. Cells were then incubated with Fc blockers for 15 min
at RT, stained with fluorescent anti-CD45 and anti-CD3 antibodies, as well as with Zombie
Aqua Fixable Viability kit (Biolegend), and analyzed by flow cytometry. The total numbers
of CD3+ and CD45+ cells per gram of the small intestine in each mouse were normalized
to those of the WT group for each experiment.
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4.2.3 Ibidi μ-slide migration assay
Resting splenic CD4+ T cells and blood neutrophils were tested in the Ibidi μ-slide
migration assay to determine the migration directionality and speed, according to
manufacturer’s instructions (Ibidi). Briefly, resting WT, Tnfaip8-/-, Tipe2-/-, and DKO
splenic CD4+ T cells or neutrophils as prepared in the Transmigration Assay above were
suspended in migration buffer (RPMI medium supplemented with 5% FBS and 1%
HEPES), and loaded into Collagen IV-coated Ibidi μ-slides. After resting for 30-45 min at
37°C, CCL21 (for T cells) or CXCL1 (for neutrophils) was added to one of the reservoirs
to a concentration of 200 ng/ml. For measuring the directionality and speed of random
migration, cells were prepared as described above but with no chemoattractant added to
the chamber. Cells were recorded every 45 sec for at least 2 h using a Leica DMI4000
microscope with Yokogawa CSU-X1 spinning disk confocal attachment at 10×
magnification. Images were analyzed by Volocity software (Perkin Elmer) using
the automated tracking protocol. Objects less than 16 μm3 and static were excluded. Tracks
less than 50 μm were also excluded. Cell velocity and vector angle between each track’s
starting and end points were obtained from Volocity using these settings. Velocity was
defined as a cell’s centroid movement in μm/min along the total path. Cell directionality
(aka Directional Meandering Index, DMI) was defined as the cosine of the migration
angle or the sine of the bearing angle. A value of 1 indicates migration directly towards the
chemoattractant, while a value of -1 indicates migration away from the chemoattractant.
The tracks were sorted by migration length, and tracks were selected from the middle of
the videos (track time was ~60 min).
100

4.2.4 PtdIns(3,4,5)P3 measurement in live CD4+ T cells using biosensors
The PtdIns(3,4,5)P3 in live cells was visualized using EGFP-tagged AKT-PH
domain, which specifically binds to this phosphoinositide. Briefly, splenic CD4+ T cells
were stimulated with anti-CD3 and anti-CD28 for 40 h, and then transfected with GFP-C1AKT-PH vector (Addgene) using mouse T cell Nucleofector Kit and Amaxa Nucleofector
II (program X-001, Lonza). Cells were cultured for 24 h after the transfection in the
presence of 10 ng/ml IL-2. The live CD4+ T cells were purified using the Dead Cell
Removal Kit (Miltenyi Biotec), cultured in fibronectin-coated slide chambers for 45 min,
and then stimulated with 600 ng/ml CCL21 applied as a point source from a pipette, in the
presence of 5 μM latrunculin A, at 37°C. The cells were recorded every 10 sec for at least
480 sec using a DeltaVision OMX-SR super-resolution microscope at 60× magnification.
The images were analyzed using Volocity and ImageJ softwares. The relative
Ptdins(3,4,5)P3 level in each cell was calculated as follows: fluorescence intensity of 50%
of the cell perimeter that faced the source of the chemokine / fluorescence intensity of 50%
of the cell area that faced the source of the chemokine.

4.2.5 Immunofluorescence confocal microscopy of fixed CD4+ T cells
Resting splenic CD4+ T cells as prepared in the Transmigration Assay above were
subjected to point-source stimulation with CCL21 at 1 µg/ml for 0, 1, and 10 min at 37°C.
Cells were immediately fixed with 3% paraformaldehyde in PBS for 15 min at 37°C,
permeabilized in PBS containing 0.1 % Triton X-100 and 3% BSA for 10 min at RT, and
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blocked with PBS containing 5% normal goat serum and 3% BSA for 1 h at RT. The cells
were stained overnight at 4°C with anti-TIPE2, anti-TNFAIP8 (Proteintech), or anti-Rac1GTP (NewEast Biosciences) in 3% BSA, and then for 1 h at RT with secondary anti-rabbit
IgG Fab-AlexaFluor 555, or anti-mouse IgM Fab-Alexa Fluor 488 (Thermo Fisher
Scientific) in 3% BSA. Slides were dried and covered with ProLong Gold with DAPI
(Invitrogen). Images were acquired on a Zeiss LSM 510 NLO/META and Zeiss LSM 710
confocal microscope and analyzed using LSM Image Browser, Zen lite (Zeiss), and ImageJ
software. Up to 120 cells of each type and condition were analyzed. Morphological cell
polarization was determined by phase contrast or differential interference microscopy.
Unpolarized T cells were of round shape whereas the polarized cells had flat leading edges
at the front (lamellipodia) and contracted uropodia at the rear. The Rac1-GTP polarization
index was calculated using ImageJ by manually selecting each cell and then determining
the coordinates for the center of the object (Xobject, Yobject), and comparing that to the center
of Rac1 fluorescent signal (Xsignal, Ysignal), using the following formula that calculated the
cellular polarization in terms of cartesian displacement of the center of the object from the
$

2

center of the signal: 1 − #$%&'()* ∗ 2%&'()* #.
+,-./0

+,-./0

4.2.6 Imaging Flow Cytometry
The ImageStream (Amnis) two camera system with 405, 488 and 658 nm lasers
was used for imaging flow cytometry. The system was calibrated using SpeedBead
(Amnis) prior to use and samples were acquired at optimized laser strength (50-100 mW)
with an area classifier (number of pixels in μm2) set at 25. Images (TNFAIP8 or TIPE2 in
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channel 11, nucleus in channel 7, F-actin in channel 2, CD4 in channel 3, and bright field
in either channel 1 or 9) were acquired for each cell at 60× magnification and ~20,000 cells
were analyzed for each sample, and 2,000 cells were acquired for each compensation
control. The integrated software INSPIRE (version 6.0.154, Amnis) was used for data
collection. Analysis was performed on the compensated image files using algorithms in
IDEAS (version 4.1.146, Amnis) image analysis software. The bright field area versus
aspect ratio features were plotted and used to gate on single cells. The gradient root mean
square (GRMS) was used to gate on cells that were in focus. The bright field aspect ratio
score was plotted against a normalized frequency of cells to generate histograms. Polarized
cells were defined as those that had low aspect ratio scores (<0.5) whereas unpolarized
cells were those that had high aspect ratio scores (>0.8).

4.2.7 Experimental autoimmune encephalomyelitis (EAE)
The induction and clinical scoring of EAE in mice were performed as we described
previously (Hilliard et al., 2002). Spinal cords of mice were harvested at the end of each
experiment, fixed, paraffin-embedded, and sectioned. The sections were stained with
hematoxylin and eosin, and analyzed using a wide field light microscope.

4.2.8 Bone marrow chimeric experiments
Bone marrow chimeric mice were generated as we described (Hilliard et al., 2002).
Briefly, WT or DKO mice were sub-lethally irradiated, and injected intravenously with
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bone marrow cells from DKO or WT mice (107 cells/mouse). For the mixed bone marrow
chimeric experiment, bone morrow cells from CD45.1 WT and CD45.2 DKO mice were
mixed at 1:1 ratio and injected into sub-lethally irradiated CD45.1 WT recipient mice.
Seven weeks after bone marrow cell transfer, EAE was induced with myelin
oligodendrocyte glycoprotein (MOG) 35-55 peptide, and scored on a scale of 0-5 as we
described (Hilliard et al., 2002).

4.2.9 Adoptive transfer of EAE
Donor mice were immunized with MOG peptide and splenocytes were collected 7
days later. After stimulation with 20 μg/ml MOG peptide for three days in culture and
removal of dead cells, the splenocytes were subjected to negative selection using EasySep
Mouse CD4+ T Cell Isolation Kit (STEMCELL, Cambridge, MA). The purified CD4+ cells
were injected to Rag2-/- recipient mice (2-3 x 106 cells/mouse) intravenously. Pertussis
toxin (100 ng/mouse) was injected intraperitoneally on the day of the cell transfer and the
day after. EAE was scored on a scale of 0-5 as we described (Hilliard et al., 2002).

4.2.10 Leukocyte tracking in mice
WT and Tnfaip8-/-Tipe2-/- KO mice were immunized with MOG35-55 peptide as
we described (Hilliard et al., 2002). Two weeks later, splenocytes were harvested and
stimulated with MOG35-55 peptide (20 µg/ml) for 3 days. Live WT and KO cells were
then labeled with fluorochromes CMTMR and CMFDA, respectively, mixed at 1:1 ratio,
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and injected via tail vein (1 million cells/mouse) into B6 mice that had been immunized
for EAE ten days earlier with MOG. Mice were sacrificed on the day of EAE onset, and
their blood, spleens, and spinal cords collected. The percentages of transferred WT and KO
cells among total leukocytes isolated from each sample were determined by flow
cytometry.
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4.3 Results
4.3.1 Complete loss of the directionality of leukocytes deficient in TNFAIP8 and
TIPE2
To determine the potential roles of TIPE2 and TNFAIP8 in T lymphocyte
migration, we isolated splenic CD4+ T cells from wild-type (WT), Tipe2–/–, Tnfaip8–/–, and
Tipe2–/–Tnfaip8–/– (double knockout, or DKO) C57BL/6 mice, and studied them in both µslide (for two-dimensional migration) and Transwell chamber (for transmigration) assays.
We found that TIPE2 and TNFAIP8 deficiency completely abolished the directionality of
T cells during chemokine-induced migration (chemotaxis) (Figure 4.1). Specifically, in the
µ-slide assay, time-lapse video microscopy that tracked the trajectory of individual
migrating cells following treatment with chemokine CCL21 revealed that the WT T cells
had a directionality of 0.79±0.08 (with 1.00 being the highest value of directionality); this
was reduced to 0.02±0.12 for the DKO T cells (Figure 4.1a, b). WT T cells traveled with
an average velocity of ~12 µm/minute, which was only slightly reduced for DKO T cells
(Figure 4.1c). Notably, WT and DKO T cells not treated with chemokines migrated
randomly with much-reduced speed (6.89 µm/minute for WT and 6.60 µm/minute for
DKO group) and directionality (Figure 4.2a, b), indicating that chemokines could increase
migration speed of both WT and KO T cells through chemokinesis. Importantly, deficiency
in either TIPE2 or TNFAIP8 alone did not significantly affect either directionality or
velocity. These results indicate that TIPE2 and TNFAIP8 play redundant roles in
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controlling T cell directionality, and loss of one can be adequately compensated by the
other.
Similarly, in the transwell assay, DKO T cells exhibited a severe defect in
transmigration, although TIPE2 deficiency alone, but not that of TNFAIP8, also
significantly reduced T cell transmigration (Figure 4.1d). The transmigration of both WT
and DKO T cells could be reduced by inhibitors for either PI3-kinases (PI3Ks) or Rac, but
the difference between WT and DKO T cells disappeared only in the presence of the Rac
inhibitor (Figure 4.1e), suggesting that Rac is important for TIPE regulation of T cell
migration. By flow cytometry, we found that the majority of migrating cells in this assay
were central memory T cells (CD4+CD44highCD62L-).
Notably, neither TIPE2 nor TNFAIP8 deficiency jeopardized random migration, as
transmigration of single or double KO T cells in the absence of chemokines were either
normal or slightly increased as compared to WT T cells (Figure 4.2c). Furthermore,
chemokine CCL21 appeared to increase random transmigration of both WT and KO T cells
(presumably through chemokinesis), since the chemokine-induced transmigration (Figure
4.1d) was calculated by subtracting random migration (Figure 4.2c) from total migration.
The effect of TIPE2 and TNFAIP8 on T cell migration was not limited to CCL21.
CXCL12-induced migration of CD4+ T cells was also significantly reduced in DKO group
(Figure 4.2d). Additionally, the critical roles of TIPE2 and TNFAIP8 in establishing cell
directionality were not restricted only to T cells. We previously reported that TIPE2
deficiency in murine neutrophils partially affected their chemotaxis (Fayngerts et al.,
2017). Here we extended that observation to TNFAIP8 and found that neutrophils deficient
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in both TIPE2 and TNFAIP8 completely lost their directionality (from 0.62±0.08 in the
WT to 0.04±0.04 in the DKO group), while preserving relatively high migrating speed in
response to chemokine CXCL1 (Figure 4.2e, f). Thus, TIPE proteins selectively control
the direction of migration with minimal effects on the migration speed of leukocytes.
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Figure 4.1 Complete loss of directionality, but not speed, of TIPE-deficient T cells
a-c, Migration tracks (a), directionality (b), and speed (c) of CD4+ T cells from
WT, Tnfaip8-/-, Tipe2-/-, and Tnfaip8-/-Tipe2-/- (DKO) mice (4 mice per group), in
response to CCL21, as determined in the μ-slide migration assay. n=25 cells per group
(a); n=30 cells for WT, 31 for Tnfaip8-/-, 29 for Tipe2-/- and 36 for DKO group (b, c). d,
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e, Transmigration of CD4+ T cells from mice of the indicated genotypes (4 mice per
group) (d, n=18 samples per group), or cells treated with the PI3K inhibitor LY290004
or Rac inhibitor NSC23766 (e, n=12 per group), as determined in the transwell
transmigration assay with CCL21. Data are representative of at least three independent
experiments (a-c), or are pooled from four (d) or three experiments (e). Values are mean
± s.e.m. of n biologically independent samples (b-e). *P < 0.05; **P < 0.01; ***P <
0.001; ****P < 0.0001 (Mann-Whitney U test (b) or Student’s t-test (c-e)).
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Figure 4.2 Effects of TIPE deficiency on T cell and neutrophil migration
a, b, Directionality (a) and speed (b) of CD4+ T cells from WT and DKO mice (5 mice
per group), in the absence of added chemokines, as determined in the μ-slide migration
assay. n=49 cells for WT, and 84 for DKO group. c, Percentages of transmigrated CD4+
T cells of the indicated genotypes in the absence of added chemokines as determined in
the transmigration assay described in Fig. 1d (n=18 samples per group). d, Percentages
of transmigrated CD4+ T cells of WT and DKO groups (n=6 samples per group) in the
presence of CXCL12. e, f, Directionality (e) and speed (f) of neutrophils from WT and
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DKO mice (4 mice per group), in response to CXCL1, as determined in the μ-slide
migration assay. n=31 cells for WT, and 79 for DKO group. Values are mean ± s.e.m.,
and are pooled from two (d) or four (c), or are representative of three (e, f) or two (a, b)
independent experiments. *P < 0.05; **P < 0.01; ****P < 0.0001 (Student’s t-test (a, b,
c, d, e, f) )
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4.3.2 TNFAIP8 and TIPE2 pilot lymphocytes through PI3Ks and Rac
To explore how TNFAIP8 and TIPE2 control cell directionality, we studied PI3Ks
and Rac signals, as well as morphological polarization of T cells. PI3Ks signaling was
measured in live T cells using a PtdIns(3,4,5)P3-specific biosensor, i.e., the enhanced green
fluorescent protein (eGFP)-tagged AKT-PH domain. By time-lapse video microscopy, we
compared PtdIns(3,4,5)P3 generation in WT and DKO T cells in response to point-source
CCL21 stimulation over a period of 110 seconds (Figure 4.3a). CCL21-induced
PtdIns(3,4,5)P3 production occurred immediately after chemokine stimulation, at the side
of the cell that faced the chemokine source, reaching its peak level ~60 seconds later. By
contrast, no significant increases in PtdIns(3,4,5)P3 were observed in DKO T cells.
Consistent with these observations, chemokine-induced morphological polarization was
significantly reduced in DKO T cells as compared to WT T cells (Figure 4.3b). TIPE2 has
been reported to be a global inhibitor of Rac (Fayngerts et al., 2017; Z. Wang et al., 2012).
In support of this view, Rac-GTP polarization occurred constitutively in DKO T cells,
which was not further increased by chemokine treatment (Figure 4.3c, d). By contrast, WT
T cells responded to the chemokine treatment by polarizing their Rac-GTP. These results
indicate that TIPE proteins are essential for generating the phosphoinositide and Rac
signals required for steering cells toward chemoattractants.
TIPE2 and TNFAIP8 were present in most parts of the cytosol and plasma
membrane in unpolarized T cells. By contrast, in polarized T cells, both TIPE2 and
TNFAIP8 moved to the leading edges of the cells, overlapping with F-actin (Figure 4.4a,
b). During the CCL21-induced chemotaxis, leading edges of WT T cells were generated
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mostly by pseudopod splitting, consistent with reports from others for granulocytes and
Dictyostelium discoideum cells (Insall, 2010). In contrast, DKO T cells generated their
leading edges by de novo pseudopod formation as frequently as pseudopod splitting
(Figure 4.4c), indicating that the latter cells might have lost the ability to follow chemokine
gradient.
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Figure 4.3 Essential roles of TIPE proteins in chemokine-induced PtdIns(3,4,5)P3
generation, and morphological and Rac1-GTP polarization
a, PtdIns(3,4,5)P3 levels detected by AKT-PH-GFP biosensor in live WT and DKO
CD4+ T cells, in response to point source stimulation of CCL21, as visualized by superresolution fluorescence video microscopy. Upper panels show a WT and a DKO T cells
60 sec after CCL21 stimulation, with arrows pointing to the source of CCL21. The lower
panel shows the changes in PtdIns(3,4,5)P3 levels relative to Time 0 when CCL21 was
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applied; values are mean ± s.e.m., with n=20 cells for each group. b, Morphological
polarization of WT and DKO CD4+ T cells, in response to point source stimulation of
CCL21, as visualized by phase contrast microscopy. Upper panels show a polarized WT
and an unpolarized DKO T cells 10 min after CCL21 stimulation. The lower panel
shows the percentages of polarized and unpolarized cells 10 min after CCL21
stimulation; n=308 cells for WT and 304 cells for DKO group. c, d, Rac1-GTP
polarization in WT and DKO CD4+ T cells, in response to point source stimulation of
CCL21, as visualized by immunofluorescence microscopy. Panel-c shows WT and DKO
T cells 60 sec after incubation with CCL21 or medium alone (Control). Panel-d shows
the calculated polarization index of each group treated as in Panel-c; n=16-24 cells for
WT and 17-18 for DKO group. Values are mean ± s.e.m. The experiments were repeated
independently at least three times (a-d) with similar results. *P < 0.05; **P < 0.01; ****P
< 0.0001 (Mann-Whitney U test (a) or Fisher’s exact test (b) or Student’s t-test (d)).
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Figure 4.4 TIPE protein polarization, and pseudopod formation in CD4+ T cells
a, b, Visualization of TNFAIP8 (a) and TIPE2 (b) together with F-actin and CD4 in
polarized and unpolarized WT CD4+ T cells 10 min after CCL21 stimulation by confocal
imaging flow cytometry. c, Percentages of pseudopods formed de novo (DN) or by
splitting the existing pseudopods (with a splitting angle < 90°) of WT and DKO T cells
0 to 120 sec after point source stimulation with CCL21, calculated by live cell video
microscopy; n=9 samples for each group. Values are mean ± s.e.m. (c). The experiments
were repeated at least three times with similar results (a-c). *P < 0.05 (Student’s t-test
(c)).
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4.3.3 Abnormal positioning of leukocytes in mice deficient in TNFAIP8 and TIPE2
under steady state
Lymphocytes are deployed strategically throughout the body via two distinct modes
of migration: directed and random migrations (Stachowiak, Wang, Huang, & Irvine, 2006;
Xiong, Huang, Iglesias, & Devreotes, 2010). The degree to which each mode of migration
contributes to the deployment of lymphocytes in each tissue is not well understood.
Chemokines enhance not only directed migration but also random migration (Figure 4.1)
(Stachowiak et al., 2006; Szatmary & Nossal, 2017). The selective defect in directed, but
not random, migration of leukocytes deficient in TIPE2 and TNFAIP8 allowed us to
examine the contribution of directed migration to tissue-specific deployment of leukocytes
in mice. Deficiency in TIPE2 and TNFAIP8 significantly increased the total numbers of
white blood cells (WBC) in the blood, which included both lymphocytes and neutrophils
(Figure 4.5a). Deficiency in TIPE2 alone, but not in TNFAIP8, also significantly increased
blood leukocyte numbers. The total CD4+CD8- and CD8+CD4- T cells in the thymus were
also significantly increased in DKO mice (by ~2 fold) (Figure 4.5b). By contrast, the total
CD4+CD8- and CD8+CD4- T cells in the spleen were significantly decreased in DKO mice
(Figure 4.5c), suggesting a defect in T cell migration from thymus to spleen. The numbers
of other leukocyte subsets except that of CD11b+Ly6G+ cells in the spleen were not
significantly affected by TIPE2 and TNFAIP8 deficiency. The weights of, and total
numbers of cells in, lymphoid organs, which included thymus, spleen, and mesenteric
lymph node, were not significantly affected by TIPE2 and TNFAIP8 deficiency (Figure
4.6). This is consistent with our previous report that C57BL/6 mice deficient in either
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TIPE2 or TNFAIP8 alone do not have significant changes in their total lymphocyte
numbers in lymphoid organs under the steady state (before 10 weeks of age) (H. Sun et al.,
2015; Z. Wang et al., 2012). These results indicate that, under steady state, directed
migration is critical for T cell deployment to lymphoid organs, and that random migration
(which can be significantly enhanced by chemokines) also plays an important role in
leukocyte deployment to lymphoid organs.
Under steady-state, ~50% of T lymphocytes in the body are deployed to the
mucosal epithelium (Guy-Grand et al., 2013). How intraepithelial lymphocytes (IELs)
move into the mucosal epithelium is not well understood. Remarkably, the total numbers
of CD45+ and CD3+ IELs in the intestinal epithelium decreased by ~50% in DKO mice
(Figure 4.5d). This indicates that about half of the IELs move to the intestinal epithelium
through TIPE-dependent migration.
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Figure 4.5 Abnormal positioning of leukocytes in tissues of TIPE-deficient mice
under the steady state
a, The total white blood cell, lymphocyte, and neutrophil counts of the blood of normal
6-8-week-old WT (n=37), Tnfaip8-/- (n=10), Tipe2-/- (n=15), and DKO (n=35) mice. b,
The numbers of the indicated cell subsets of thymus of WT (n=6) and DKO (n=8) mice
as determined by flow cytometry. CD4+ and CD8+ denote the respective single positive
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cells; DP denotes double positive cells; DN denotes double negative cells. c, The
numbers of the indicated cell subsets of spleen of WT (n=6) and DKO (n=8) mice as
determined by flow cytometry. d, Relative numbers of the indicated intraepithelial cells
per mg of small intestine of WT (n=10 mice for CD45+ and 9 for CD3+ cells) and DKO
(n=13 for CD45+ and 8 for CD3+ cells) mice as determined by flow cytometry. Data are
normalized to the mean of the respective WT group. The values are mean ± s.e.m. (a-d),
and are pooled from two (b-c) or three (a, d) independent experiments. *P < 0.05; **P <
0.01; ***P < 0.001 (Student’s t-test (a-d)).
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Figure 4.6 Weights and total cell numbers of thymus, spleen and mesentery lymph
node
a, b, Total numbers of thymocytes (a) and splenocytes (b) of each 8-week-old WT
(n=14), Tnfaip8-/- (n=10), Tipe2-/- (n=8), and DKO (n=15) mouse. c. Total numbers of
mesentery lymph node cells of WT (n=8), Tnfaip8-/- (n=7), Tipe2-/- (n=6), and DKO
(n=8) mice. d-f, Weights of thymus (d), spleen (e), and mesentery lymph node (f) of the
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mice used in a-c. The values are mean ± s.e.m., and are pooled from three independent
experiments (Student’s t-test)(a-f).
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4.3.4 Resistance of mice deficient in TNFAIP8 and TIPE2 to autoimmune
encephalomyelitis
Under inflammatory conditions, lymphocytes can exit the blood circulation and
enter non-lymphoid tissues. This is crucial for the development of inflammatory diseases
such as multiple sclerosis (MS) (Calabresi et al., 2014; Derfuss et al., 2013). To determine
the roles of TIPE2 and TNFAIP8 in experimental autoimmune encephalomyelitis (EAE),
an animal model for MS, we immunized WT, Tipe2–/–, Tnfaip8–/–, and Tipe2–/–Tnfaip8–/–
DKO mice with myelin oligodendrocyte glycoprotein (MOG) peptide 35-55, and
monitored daily for clinical signs of EAE (Figure 4.7a). We found that the onset and mean
EAE scores were significantly reduced in all knockout groups with the DKO group being
the most affected. This indicates that TIPE2 and TNFAIP8 play redundant roles in EAE,
and loss of one is significantly compensated by the other. The fatality was reduced from
60% in the WT group to 0% in all KO groups. Consistent with these clinical findings,
histological examination of spinal cord sections revealed significant differences in the
degree of leukocyte infiltration between WT and KO groups (Figure 4.7b, c). In the WT
group, multiple inflammatory foci were observed, with extensive leukocyte infiltration into
the white matter. By contrast, leukocyte infiltration in KO mouse spinal cords was much
less pronounced.
To define the roles of TIPE2 and TNFAIP8 expressed by hematopoietic cells, we
studied EAE in irradiated WT and DKO female C57BL/6 mice that had received bone
marrow from either WT or DKO mice 7 weeks earlier (Figure 4.7d). In the chimeric mice,
~90% of leukocytes were derived from donor bone marrow as determined by flow
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cytometry. Notably, following immunization with MOG peptide, mice that received DKO
bone marrow developed significantly less EAE than those reconstituted with WT cells.
Therefore, loss of TIPE2 and TNFAIP8 in hematopoietic cells alone is sufficient to
significantly hinder the development of EAE. Because not all hematopoietic cells in
recipient mice can be eliminated by irradiation, whether and to what degree TIPE proteins
expressed by non-hematopoietic cells contribute to EAE cannot be conclusively
established in this model.
MOG-induced EAE is a T cell-initiated disease. To determine whether TIPE
deficiency in T cell alone is sufficient to affect EAE, we adoptively transferred activated
anti-MOG T cells from WT and DKO mice into Rag2-deficient B6 mice (that had
endogenous myeloid but not lymphoid cells). We found that EAE was significantly
diminished in mice received DKO T cells (Figure 4.8a). To measure anti-MOG responses
of T cells, mice were sacrificed 10 days after immunization, and their splenocytes cultured
in the presence of the MOG peptide. DKO cell cultures produced increased interleukin
(IL)-2 and IL-17A as compared to WT cultures (Figure 4.7e, f). Because the frequency of
MOG-specific T cells in different groups could be different, we also compared responses
of purified CD4+ T cells from naïve mice to anti-CD3 and anti-CD28 stimulation in vitro.
Similar to its effect on anti-MOG responses, TIPE2 and TNFAIP8 double deficiency
increased T cell responses to anti-CD3 and anti-CD28 stimulation (unpublished data).
These results indicate that reduced EAE in TIPE-deficient mice is not due to reduced T cell
responses to MOG.
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4.3.5 Abnormal positioning of leukocytes in the central nervous system of mice
deficient in TNFAIP8 and TIPE2 during autoimmune encephalomyelitis
Reduced EAE in TIPE-deficient mice could be due to reduced migration of KO T
cells into the central nervous system (CNS), to which access of leukocytes is tightly
controlled by the blood-brain barriers (Engelhardt & Ransohoff, 2012; Minagar &
Alexander, 2003). In the mixed bone marrow chimeric mice that had both CD45.1 WT and
CD45.2 DKO T cells, markedly reduced numbers of DKO T cells were found in the CNS
as compared to WT T cells, following the onset of EAE (Figure 4.8b). Similarly, upon cotransfer into mice with EAE, CMTMR-labeled DKO cells showed a marked defect in
infiltrating CNS, as compared to CMFDA-labeled WT cells in the same mice (Figure 4.8c).
This was accompanied by a significant increase of the transferred DKO cells in the blood
and spleen of the mice. These results indicate that T cells deficient in TNFAIP8 and TIPE2
have a severe defect in infiltrating the CNS during neural inflammation.
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Figure 4.7 The effects of TIPE deficiency on EAE, leukocyte infiltration of the
nervous tissue, and T cell response to MOG
a, Clinical EAE scores of WT, Tnfaip8-/-, Tipe2-/-, and DKO mice (n=5 for each group)
immunized with MOG35-55 peptide. b, Spinal cord sections stained with hematoxylin
and eosin of WT and DKO mice. Scale bar = 50 μm. c, The numbers of leukocytes
isolated from each spinal cord of WT (n=8) and DKO (n=6) mice 20 days after
immunization with MOG. d, EAE scores of irradiated WT and DKO mice (n=5 for each
group) that had received WT or DKO bone marrow cells before being immunized with
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MOG. e, f, The concentrations of IL-17A (e) and IL-2 (f) in the splenocyte cultures of
WT and DKO EAE mice (n=4 per group), cultured with or without the MOG peptide for
24 h, as measured by ELISA. Data are representative of two (d) or three (a, b)
independent experiments, or are pooled from two experiments (c, e, f). Values are mean
± s.e.m. *P < 0.05; **P < 0.01; ***P < 0.001 (Mann-Whitney U test (a, d) or Student’s
t-test (c, e, f)).
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Figure 4.8 Abnormal positioning of leukocytes in the nervous tissue of TIPEdeficient mice during encephalomyelitis
a, EAE scores of Rag2-/- mice (n=4 mice per group) that were injected with MOGspecific WT or DKO CD4+ T cells. b, The percentages of WT CD45.1+ and DKO
CD45.2+ T cells among total CD3+ T cells in the blood (BLD) and spinal cord (Sp Cord)
of EAE mice (n=7 mice per group) that were injected with WT and DKO bone marrow
cells at 1:1 ratio. Samples were collected one day after EAE onset. c, The percentages of
transferred CMTMR-labeled WT and CMFDA-labeled DKO cells among total
leukocytes in the blood (BLD), spleen (SPL), and spinal cord (Sp Cord) of EAE mice
(n=5 mice per group) that were injected with the respective MOG-specific WT and DKO
CD4+ T cells at 1:1 ratio. Samples were collected on the day of the EAE onset. The
values are mean ± s.e.m. (a-c), and are pooled from two independent experiments (b, c)
or are representative of four independent experiments (a). *P < 0.05; **P < 0.01; ****P
< 0.0001 (Mann-Whitney U test (a, b) or Student’s t-test (c)).
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4.4 Discussion
Results in this study prompted us to propose that TIPE proteins are the long-soughtafter molecular pilot of leukocytes (Figure 5.2). Following chemokine receptor activation,
TIPE proteins serve as the pilot of cell migration by steering cells along the chemokine
gradient through at least two distinct mechanisms (Figure 5.2). First, at the membranecytosol interface, PI3Ks alone may not be effective in catalyzing reactions of membraneanchored phosphoinositides (Schaaf et al., 2008). Because of its unique membrane-cytosol
interfacial localization and its water solubility, TIPE-anchored PIP2 serves as a “primed’
or “presented” substrate for PI3Ks. Therefore, at the cell front, TIPEs promote leading edge
formation by enhancing/exciting phosphoinositide signaling, leading to enhanced
recruitment and activation of the downstream signaling molecules. Second, in the cytosol
or away from the leading edge, the water soluble TIPEs serve as an inhibitor of Rac,
preventing it from moving to the membrane as we reported (Z. Wang et al., 2012). This
inhibitory mechanism is important for maintaining the polarized state of the cell, i.e., by
preventing additional leading edge formation. Thus, by regulating both PI3Ks and Rac,
TIPE proteins confer the directionality of migration. In summary, we discovered that TIPE
family of proteins controls lymphocyte migration and deployment in healthy and diseased
animals. These results may not only advance our understanding of the biology of
lymphocyte trafficking but also help develop new TIPE-based strategies to treat
lymphocyte-related diseases. For example, agents that block TIPE function could be
effective for treating inflammatory diseases such as MS. However, the same agents could
also reduce the host’s ability to mobilize immune cells to fight against infectious microbes.
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Therefore, future studies are needed to evaluate the therapeutic and adverse effects of
TIPE-blocking agents for the treatment of inflammatory diseases.
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CHAPTER 5

DISCUSSION AND FUTURE DIRECTIONS
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5.1 Global inhibitor and local enhancer theory
Several lines of evidence in this study establish that TNFAIP8 plays an important
role in cell migration by acting as a “dual-role regulator” in response to external stimuli
(Figure 5.1 and Figure 5.2). Our results support that TNFAIP8 can control the spatial and
temporal distribution of GPCRs downstream signaling, and mediate the activities of
phosphoinositide-binding proteins. It can enhance the generation of PtdIns(3,4,5)P3 at the
front membranes, therefore reinforcing a positive feedback loop that amplifies the PI3K
signaling at the leading edge. Besides the PI3K-dependent pathway, TNFAIP8 interaction
with PtdIns(4,5)P2 may also result in release and diffuse of the plasma membrane (PM)bound pool of unphosphorylated and inactive cofilin to the nearby F-actin compartment (to
actively exert its severing function). In addition, TNFAIP8 can serve as a cytosolic
inhibitor of Rac/Cdc42 and function through the PAK-LIMK-cofilin pathway, thus
controlling trailing edge formation and suppressing secondary leading edge generation
(Bravo-Cordero et al., 2013; Ghosh et al., 2004). This way TNFAIP8 may be built into a
machinery of both short-range positive feedback and long-range inhibition, which helps to
amplify and translate the shallow chemical gradients into axes of cell polarity.
These findings are consistent with the computationally predicted existence of
essential regulators that operate as local enhancers and global inhibitors, relaying
chemokine-induced signal transduction for cytoskeletal dynamics (Huang, Tang, Shi,
Iglesias, & Devreotes, 2013; Iglesias & Devreotes, 2012; Kamakura et al., 2013; Tang et
al., 2014; Thapa & Anderson, 2012). In this LEGI-BEN (local-excitation, globalinhibition-biased excitable network) model, the enhancers operate locally at the leading
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edge, whereas the inhibitors function globally (Bhowmik, Rappel, & Levine, 2016; Xiong
et al., 2010). It has been suspected that migrating cells may possess an internal compass
that controls the directionality of migration (Franca-Koh & Devreotes, 2004; Rickert et al.,
2000; Swaney et al., 2010). Recent studies revealed that only moderate effects on
chemotaxis were observed in the PI(3)Kγ−/− cells, suggesting that when phosphoinositide
levels were reduced, signaling through another parallel pathway may compensate for this
defect (Ferguson et al., 2006; Nishio et al., 2006). Consistent with the proposed compass
model for directional sensing (Franca-Koh, Kamimura, & Devreotes, 2007), receptor
signaling through GPCRs may orient the cell’s compass and activate the PtdIns(3,4,5)P3
pathway and parallelly the TIPE regulated pathway for controlling chemotaxis (Figure 5.2).
Rho family of small GTPases are well known to be regulated by GEFs, GAPs and
RhoGDIs. RhoGDIs can inhibit Rac by extracting prenylated Rac-GDP from plasma
membrane and by decreasing the rate of nucleotide dissociation. RhoGDIs have also been
reported to be able to prevent the degradation of Rho GTPases. Our study reported here
indicates that TIPE family might represent a unique class of negative regulator of Rho
GTPases, distinct from the aforementioned molecules. Since TIPE2 preferentially
associates with dominant negative Cdc42-17N but not the constitutively active Cdc42-61L
mutant, it is possible that TIPEs may bind and stabilize an inhibitory complex, which is
dissociated by GPCR signaling upon chemokine stimulation. TIPEs may thus maintain the
quiescent cellular state by sequestering PtdIns(4,5)P2, Rho GTPases and/or heterotrimeric
G proteins in the cytosolic pool. TIPEs might also use similar mechanisms of RhoGDIs to
inhibit Rho GTPases and prevent their membrane translocation as well as function.
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Figure 5.1 A schematic model of TNFAIP8 actions
TNFAIP8 can enhance the generation of PtdIns(3,4,5)P3 at the front membranes,
therefore reinforcing a positive feedback loop that amplifies PI3K signaling at the
leading edge. TNFAIP8 interaction with PtdIns(4,5)P2 may also result in release and
diffuse of the plasma membrane (PM)-bound pool of unphosphorylated and inactive
cofilin to the nearby F-actin compartment. In addition, TNFAIP8 can serve as a cytosolic
inhibitor of Rac/Cdc42 and function through the PAK-LIMK-cofilin pathway, thus
controlling trailing edge formation and suppressing secondary leading edge generation.
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Cofilin

Figure 5.2 TIPE proteins can confer the directionality of migration by regulating
both PI3Ks and Rho GTPases
TIPEs can regulate polarization in a spatial-specific manner and direct cell migration.
Following GPCR activation, TIPE proteins serve as the pilot of cell migration by steering
cells along the chemokine gradient through two distinct mechanisms. First, because of
their unique membrane-cytosol interfacial localization and water solubility, TIPEsanchored PIP2 serves as a “primed” substrate for PI3Ks. Therefore, at the cell front
TIPEs promote leading edge formation by enhancing phosphoinositide signaling, leading
to recruitment and activation of the downstream cascades. Second, in the cytosol or away
from the leading edge, the water soluble TIPEs serve as an inhibitor of Rho GTPases
such as Rac, preventing it from membrane translocation/activation. This inhibitory
mechanism is important for preventing multiple leading edge formation and thus
maintaining the polarization of the cell.
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5.2 Conservative functions of TIPE family proteins
The TIPE TH domain is highly homologous among TIPE family members, and
conserved through evolution in vertebrates. TIPE2 has been reported to be able to regulate
both carcinogenesis and inflammation (Gus-Brautbar et al., 2012), and is crucial for the
polarization of myeloid cells (Fayngerts et al., 2017; H. Sun et al., 2008). We have also
recently found that TNFAIP8 and TIPE2 play redundant roles in controlling murine
lymphocyte migration. TNFAIP8 or TIPE2-deficient CD4+ T cells exhibited reduced
migration towards CCL21 gradients, while double knockout (DKO) T cells showed most
significant defects in chemotaxis. Therefore, loss of both TIPE2 and TNFAIP8, but not
either alone in lymphocytes is required to eliminate directional migration. This Dual
Molecular Redundancy (DMR) ensures that the directional migration is maintained in case
one TIPE family protein fails (resulting from gene mutation or downregulation). This
enhances the overall robustness of the biological system, similar to what the DMR does in
electric engineering (Stanisavljevic, Schmid, & Leblebici, 2009).
The functions of TIPEs may also be differentially regulated by other sequences
present in the proteins, such as the N-terminal regions. For example, the unique N-terminus
of TIPE3, which is not shared by other family members, has been reported to act in a
dominant-negative manner (Fayngerts et al., 2014). This raises the question as to whether
the many transcript variants and protein isoforms of TNFAIP8 in both mice and human
may be transcriptionally regulated to exert diverse cell-type specific functions.
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5.3 TNFAIP8 and GPCR interaction
The TH domain is conserved through evolution and is found in invertebrates such
as fruit fly, unicellular eukaryotes such as Entamoeba, as well as vertebrates. G protein
interacting protein 1 (Gip1) has recently been found to regulate GPCR signaling of
chemotaxis in eukaryote Dictyostelium discoideum by binding and sequestering
heterotrimeric G proteins in the cytosolic pool. Interestingly, the crystal structure of the Cterminal region of Gip1 shows cylinder-like folding with a central hydrophobic cavity, in
homology to TIPE TH domain (Kamimura, Miyanaga, & Ueda, 2016; Miyagawa et al.,
2018). Dictyostelium deficient in Gip1 exhibits severe defects in following the gradient of
the chemoattractant cyclic adenosine monophosphate (cAMP), indicating that Gip1 is also
essential in regulating the directional migration of Dictyostelium discoideum (Kamimura
et al., 2016). These findings suggest that the TIPE TH domain may play an important
conservative role in eukaryotic chemotaxis. These also implicate that TNFAIP8 and GPCR
complexes may interact in HL-60 cells to regulate chemotaxis.
TNFAIP8 has been reported to directly interact with Gαi and couple with Gαicoupled dopamine-D2short (D2S) receptor to reduce cell death and induce cellular
transformation (Laliberté et al., 2010). Through yeast two-hybrid screening and
confirmation by co-IP and pull-down assays, TNFAIP8, TIPE1, and TIPE2 have been
showed to preferentially interact with Gai proteins, but not other Ga proteins that not
associated with chemokine receptors. Deletion of the last 15 amino acids of TNFAIP8 Cterminus was sufficient to disrupt this interaction (Laliberté et al., 2010). Thus, it is likely
that TIPE proteins can sense chemoattractant gradient through GPCRs. We have observed
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that TIPE2 preferentially localized to the plasma membranes in dHL-60s in response to
CXCL8 treatment (Figure 2.7D). It would be interesting to test the interactions between
TNFAIP8 and Gai proteins by co-IP in HL-60 cells. We could also inhibit Gai activity by
the selective Gai inhibitor pertussis toxin and examine if this affects TNFAIP8 membrane
translocation after stimulation. These studies will clarify if Gai is responsible for recruiting
TNFAIP8 protein to the site of chemoattractant activation.

5.4 TNFAIP8 in inflammation and cancer
Existing evidences support the notion that TNFAIP8 is an oncogene in human
cancers. More than half of human cancers exhibit aberrantly dysregulated phosphoinositide
signaling, yet how these lipid signals are controlled remain not fully understood. While
somatic mutations of PI3K, PTEN and Ras account for many cases of the aberrant
phosphoinositide signaling, other mechanisms for its dysregulation are also being
discovered. We found that TNFAIP8 interacts with PtdIns(4,5)P2 and PtdIns(3,4,5)P3, and
is likely to be hijacked by tumor cells to facilitate malignant transformation. Some studies
suggest that TNFAIP8 may be an inhibitor of caspases-induced apoptosis. Reports have
shown that overexpression of TNFAIP8 in some cancer cell lines inhibited TNFa-induced
apoptosis by suppressing caspase-3 and caspase-8 activities, while TNFAIP8 knockdown
enhanced cell death (Kumar et al., 2000; C. Zhang et al., 2006). More work will be needed
to elucidate the roles of TNFAIP8 in regulating proliferation and cell death signaling in
tumorigenesis.
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TNFAIP8 is originally identified as one of the most differentially expressed genes
in primary and matched metastatic head and neck squamous cell carcinoma (HNSCC) from
the same patient (Kumar et al., 2000; Patel et al., 1997), which raises the question of
transcriptional control mechanisms of TNFAIP8 gene. TNFAIP8 expression has been
reported to be induced by TNFa and high glucose stimulation, as well as activation of NFκB in various cell types (Horrevoets et al., 1999; H.-G. Zhang et al., 2004). The orphan
nuclear receptor chicken ovalbumin upstream promoter transcription factor I (COUP-TFI)
has been identified as a transcriptional repressor of TNFAIP8 gene (Ling-juan Zhang, Liu,
Gafken, Kioussi, & Leid, 2009), which is involved in the induction of TNFAIP8 promoter
by TNFa. However, the detailed molecular mechanisms between COUP-TFI and TNFa
signaling remain elusive. These findings support the notion that TNFAIP8 links a
molecular bridge from inflammation to cancer by combining TNFa/NF-κB to
phosphoinositide signaling pathway (Figure 5.3).
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A working model in which TIPE regulates PIP delivery and synth
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Figure 5.3 TNFAIP8 links a molecular bridge from inflammation to cancer by

combining TNFa/NF-κB to phosphoinositide signaling pathway
TNFAIP8 expression can be induced by TNFa and activation of NF-κB, possibly
through COUP-TFI (which is identified as a transcriptional repressor of TNFAIP8 gene).
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5.5 Concluding remarks
In this study, we have conducted CRISPR/cas9-mediated TNFAIP8 gene knockout
in human HL-60 cell line (Figure 2.1 and Figure 2.2). In addition to decreased proliferation
and cell survival (Figure 2.3), defective migration and adhesion upon cytokine and fMLP
stimulation were observed in these differentiated neutrophil-like cells (Figure 2.5 and
Figure 2.6). We have confirmed that TNFAIP8 was in the cytosol in various cell types
under resting condition, and TIPE2 translocated to plasma membranes after cytokine
stimulation in dHL-60s (Figure 2.7). Moreover, TNFAIP8 could affect cellular
phosphoinositide levels, and we showed increased total PtdIns(3,4,5)P3 and PtdIns(4)P but
reduced PtdIns(4,5)P2 levels in TNFAIP8-deficient dHL-60 cells under resting condition
(Figure 2.8). Additionally, we confirmed increased total PtdIns(3,4,5)P3 levels in
TNFAIP8 and TIPE2-deficient murine splenocytes, thymocytes and CD4+ T cells in
quiescent states (Figure 2.9). Through pharmaceutical inhibitors, co-IP/GST pull-down and
flow cytometric studies, we have established that TNFAIP8 can regulate cell migration
through Rho GTPases-dependent signaling and cofilin-mediated actin remodeling (Figure
2.10 and Figure 2.12), which is essential for leading edge formation (Figure 2.11).
To acquire mechanistic information, we have optimized the purification of TIPE
proteins from E. coli (Figure 3.1 and Figure 3.2) and showed TNFAIP8 protein interacts
with PtdIns(4,5)P2 and PtdIns(3,4,5)P3 present in lipid bilayers using the sedimentationbased binding assay (Figure 3.3A) and SPR assay (Figure 3.3B, Figure 3.11 and Table 4).
Furthermore, we found TNFAIP8 can function as a phosphoinositide transfer protein in
vitro (Figure 3.4). We also demonstrated that TNFAIP8 protein increased the PI3K142

catalyzed conversion of PtdIns(4,5)P2 to PtdIns(3,4,5)P3 in a dose-dependent manner
through an enzymatic assay (Figure 3.5). In addition, we found TIPEs may also be able to
steer cells by remodeling actin cytoskeleton through cofilin (Figure 3.6 and Figure 3.7).
Crystal structure reveals that the fatty acid chains of phosphoinositides are likely involved
in the hydrophobic pocket formed by the α1-α6 helixes of the TIPE TH domain, while the
negatively charged phosphate head group is likely accommodated by electrostatic
interactions with the positively charged amino acids located at the entrance of the cavity as
well as the more flexible α0 helix. To provide additional insight to these hypotheses,
mutagenesis analyses were performed to explore the structure and functional significance
of the TIPE homology (TH) domain (Figure 3.8 and Figure 3.9). The effects of the
TNFAIP8 mutants predicted from mutagenesis analyses have been assessed for
phosphoinositide binding by lipid-protein overlay (Figure 3.10) and SPR assay (Figure
3.11 and Table 4) in vitro. Finally, the validated interaction-deficient mutants have been
re-expressed in TNFAIP8 knockout murine T cells and HL-60 cells for cellular function
characterization (Figure 3.12 and Figure 3.13).
We have also investigated murine leukocytes deficient in both TNFAIP8 and
TIPE2, and observed complete loss of the directionality (Figure 4.1 and Figure 4.2). We
found TNFAIP8 and TIPE2 pilot murine lymphocytes through PI3Ks and Rac (Figure 4.3
and Figure 4.4). Furthermore, We observed abnormal positioning of leukocytes in mice
deficient in TNFAIP8 and TIPE2 under steady state (Figure 4.5 and Figure 4.6).
Additionally, using experimental autoimmune encephalomyelitis (EAE) as a mouse model,
we found TNFAIP8 and TIPE2-deficient mice were resistance to autoimmune
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encephalomyelitis, and exhibited abnormal positioning of leukocytes in the central nervous
system during autoimmune encephalomyelitis (Figure 4.7 and Figure 4.8). These findings
indicate that TNFAIP8 and TIPE2 play redundant roles in controlling murine lymphocyte
infiltration.
In summary, we discovered that TNFAIP8 is important to control cell migration,
and may represent a molecular bridge from inflammation to caner by combining
TNFa/NF-κB and phosphoinositide signaling. TNFAIP8 may represent a novel negative
regulator of Rho GTPases, similar to the unique class of Rho GDP-dissociation inhibitors
(RhoGDIs). Once sensing the chemokine stimulation, possibly through GPCRs, it may
polarize along the chemoattractant gradient. Additionally, it can steer cells by enhancing
phosphoinositide signaling through PI3K and remodeling actin cytoskeleton dynamics
through cofilin. Thus, TNFAIP8 may contribute to short-range positive feedback as well
as long-range inhibition, which helps to amplify the shallow chemokine gradients into
cellular polarity. This study could not only advance our understanding of the biology of
inflammation and tumorigenesis, but also help in silico drug screening and develop new
TIPE-based strategies to combat malignant human diseases.
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The TIPE Molecular Pilot That Directs Lymphocyte Migration in Health and Inflammation

Sun, H.*, Lin, M.*, Zamani, A., Goldsmith, J.R., Boggs, A.E., Li, M., Lee, C.N., Chen, X., Li,
X., Li, T., Dorrity, B.L., Li, N., Lou, Y., Shi, S., Wang, W., Chen, Y.H. (2020). The TIPE
Molecular Pilot That Directs Lymphocyte Migration in Health and Inflammation. Scientific
Reports, 10(1), pp.1-13.
*These authors contributed equally to this work

Abstract

Lymphocytes are some of the most motile cells of vertebrates, constantly navigating
through various organ systems. Their specific positioning in the body is delicately controlled by
site-specific directional cues such as chemokines. While it has long been suspected that an intrinsic
molecular pilot, akin to a ship’s pilot, guides lymphocyte navigation, the nature of this pilot is
unknown. Here we show that the TIPE (TNF-a-induced protein 8-like) family of proteins pilot
lymphocytes by steering them toward chemokines. TIPE proteins are carriers of lipid second
messengers. They mediate chemokine-induced local generation of phosphoinositide second
messengers, but inhibit global activation of the small GTPase Rac. TIPE-deficient T lymphocytes
are completely pilot-less: they are unable to migrate toward chemokines despite their normal ability
to move randomly. As a consequence, TIPE-deficient mice have a marked defect in positioning
their T lymphocytes to various tissues, both at the steady-state and during inflammation. Thus,
TIPE proteins pilot lymphocytes during migration and may be targeted for the treatment of
lymphocyte-related disorders.
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Direction of leukocyte polarization and migration by the phosphoinositide-transfer protein
TIPE2

Fayngerts, S.A., Wang, Z., Zamani, A., Sun, H., Boggs, A.E., Porturas, T.P., Xie, W., Lin, M.,
Cathopoulis, T., Goldsmith, J.R. and Vourekas, A., 2017. Direction of leukocyte polarization and
migration by the phosphoinositide-transfer protein TIPE2. Nature immunology, 18(12), p.1353.

Abstract

The polarization of leukocytes toward chemoattractants is essential for the directed
migration (chemotaxis) of leukocytes. How leukocytes acquire polarity after encountering
chemical gradients is not well understood. We found here that leukocyte polarity was generated by
TIPE2 (TNFAIP8L2), a transfer protein for phosphoinositide second messengers. TIPE2
functioned as a local enhancer of phosphoinositide-dependent signaling and cytoskeleton
remodeling, which promoted leading-edge formation. Conversely, TIPE2 acted as an inhibitor of
the GTPase Rac, which promoted trailing-edge polarization. Consequently, TIPE2-deficient
leukocytes were defective in polarization and chemotaxis, and TIPE2-deficient mice were resistant
to leukocyte-mediated neural inflammation. Thus, the leukocyte polarizer is a dual-role
phosphoinositide-transfer protein and represents a potential therapeutic target for the treatment of
inflammatory diseases.
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